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ABSTRACT 
 
High-Oleic Ground Beef, Exercise, and Risk Factors for Cardiovascular Disease in Men 
and Postmenopausal Women. (December 2010) 
Linda Anne Gilmore, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Stephen B. Smith 
 
 Sixty-six percent of the ground beef consumed in the U.S. contains 16-30% fat by 
weight, and at the retail level, ground beef fat varies widely with regards to saturated, 
monounsaturated and trans-fatty acid content. Through two independent studies the 
effect of fatty acid composition of ground beef on selected cardiovascular disease risk 
indicators was evaluated. 
 In the first study, 27 free-living normocholesterolemic men completed a three-
way crossover dietary intervention. Subjects consumed five, 114-g ground beef patties 
per week for 5 wk with intervening 4-wk washout periods. Patties contained 24% total fat 
with monounsaturated fatty acid:saturated fatty acid (MUFA:SFA) of either 0.71 (low-
MUFA, pasture-fed), 0.83 (mid-MUFA, short-term corn-fed), or 1.10 (high-MUFA, long-
term corn-fed). Blood was collected from each subject before and at the end of each diet 
period. Overall, the ground beef interventions decreased plasma insulin, HDL2, and 
HDL3 particle diameter and α-linolenic acid (18:2 (n-3)), and increased plasma 
arachidonic (20:4(n-6)). The greatest increase in HDL cholesterol from baseline (0.07 
mmol/L) was after the high-MUFA ground beef intervention. An increase from baseline 
in LDL particle diameter (0.5 nm) occurred after the mid- and high-MUFA interventions. 
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We concluded that low-MUFA ground beef from pasture/hay-fed cattle was no more 
“heart healthy” than high-MUFA ground beef from corn-fed cattle as judged by common 
clinical criteria. 
In the second study, 19 of 29 post menopausal women completed a two-way 
crossover design. Subjects consumed five, 114-g ground beef patties per week for 6 wk 
periods separated by a 4 wk washout period. The low-MUFA patties contained 19.4% fat 
with MUFA:SFA of 0.9. The high-MUFA patties contained 22.5% fat with a 
MUFA:SFA ratio of 1.3. In addition to patty consumption, the subjects completed a bout 
of exercise during the last week of each phase. Blood was taken before, each diet phase 
(24 hr before exercise) and 24 hr post exercise. Total cholesterol was increased by the 
high-MUFA patties with the most significant increase seen in HDL cholesterol, mainly 
HDL2b subfraction. Lipid-rich lipoprotein fractions were increased with the low-MUFA 
diet, but not by the high-MUFA diet. Very long chain fatty acids were depressed by low 
MUFA patty consumption. When unadjusted for plasma volume shifts (raw), exercise 
decreased triglycerides in all three phases. Raw VLDL cholesterol was reduced after 
exercise during the intervention phases. Raw RLP and IDL cholesterol were reduced after 
exercise during the high-MUFA intervention. HDL2b was reduced after exercise during 
the high-MUFA phase. LDL mean size increased and LDL mean density decreased after 
exercise during the low-MUFA intervention. HDL mean density increased after exercise 
during both ground beef interventions. The data indicate that high-oleic ground beef can 
reduce some cardiovascular disease risk factors and can be a part of a healthful diet. 
Exercise can have a beneficial impact on cardiovascular disease risk factors independent 
and in conjunction with ground beef consumption. 
 
 v
DEDICATION 
This work is dedicated to my family. Thank you all for your unconditional love 
and support at this time and always. 
 
 vi
ACKNOWLEDGEMENTS 
I would like to thank my committee chair, Dr. Smith, and my committee 
members, Dr. Wu, Dr. Lupton, Dr. Bauer, Dr. Crouse, and Dr. Martin for their guidance 
and support throughout the course of this research. 
Thank you also to my colleagues and the department faculty and staff for making 
my time at Texas A&M University a great experience. I also want to extend my gratitude 
to the National Cattlemen’s Beef Association, which provided funding for the grass- 
versus corn-fed study, to HeartBrand Beef, which provided Waygu patties and 
discretionary funding, the J.L. Huffines Institute, which provided the exercise equipment 
testing facilities, and funding, and to all the men and women who were willing to 
participate in the study, without whom this study would not have been possible. 
 
 vii
TABLE OF CONTENTS 
 
              Page 
ABSTRACT............................................................................................................... iii 
DEDICATION........................................................................................................... v 
ACKNOWLEDGEMENTS....................................................................................... vi 
TABLE OF CONTENTS........................................................................................... vii 
LIST OF FIGURES ................................................................................................... ix 
LIST OF TABLES..................................................................................................... xiv 
CHAPTER 
 I INTRODUCTION ................................................................................ 1 
    
   Introduction..................................................................................... 1  
   Inflammation and CVD................................................................... 2 
   Lipoprotein Metabolism.................................................................. 3 
   High Density Lipoproteins.............................................................. 3 
   Very Low Density Lipoproteins ..................................................... 7 
   Low Density Lipoproteins .............................................................. 8 
   Lipoprotein(a) (Lp(a))..................................................................... 10 
   Plasma Fatty Acids and CVD .........................................................     10 
   Menopausal Status and CVD.......................................................... 11 
   Dietary Influence on CVD.............................................................. 12 
   Saturated Fats.................................................................................. 14 
   Monounsaturated Fats..................................................................... 16 
   Polyunsaturated Fats ....................................................................... 17 
   Trans-Fats ....................................................................................... 18 
   Dietary Cholesterol ......................................................................... 20 
   Exercise and Lipid and Lipoprotein Metabolism............................ 21 
   Present Study .................................................................................. 22 
    
    
    
 
  
 
  
 
 viii
CHAPTER                                                                                                               Page 
 
 II GROUND BEEF FORMULATED FROM CORN-FED CATTLE 
INCREASES HDL CHOLESTEROL AND LDL DIAMETER AND 
DECREASES PLASMA INSULIN IN  
  NORMOCHOLESTEROLEMIC MEN ............................................... 24 
   
   Introduction..................................................................................... 24 
   Methods........................................................................................... 26 
   Results............................................................................................. 33 
   Discussion....................................................................................... 43 
  
III HIGH-OLEIC GROUND BEEF AND RISK FACTORS FOR 
CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL  
 WOMEN............................................................................................... 49 
 
  Introduction.....................................................................................    49 
  Methods...........................................................................................     50 
                   Results.............................................................................................     55 
                               Discussion.......................................................................................     78 
 
       IV HIGH-OLEIC GROUND BEEF, EXERCISE AND RISK FACTORS  
  FOR CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL 
WOMEN...............................................................................................     81 
                        
                  Introduction.....................................................................................     81 
  Methods...........................................................................................     82 
                   Results.............................................................................................     85 
                               Discussion.......................................................................................     115 
                            
        V        CONCLUSIONS....................................................................................     118 
         
LITERATURE CITED ..............................................................................................     121 
VITA..........................................................................................................................     147 
 
 ix
LIST OF FIGURES 
 
FIGURE                                                                                                                         Page 
 1 Absolute changes from baseline (mmol/L) for triacylglycerol (TAG),  
  LDL-C and HDL-C in men rotated through test group beefs low in 
monounsaturated fatty acids (Low MUFA), medium in monounsaturated 
  fatty acids (Mid MUFA), or high in monounsaturated fatty acids  
  (High MUFA) ............................................................................................. 39 
 
2 Absolute changes from baseline (nm) for LDL, HDL2 and HDL3 particle 
diameter in men rotated through test group beefs low in monounsaturated  
 fatty acids (Low MUFA), medium in monounsaturated fatty acids (Mid 
MUFA), or high in monounsaturated fatty acids (High MUFA)................ 41 
  
3 Magnitude changes from baseline for glucose (mmol/L), insulin(mU/L) 
 and hs-CRP (mg/L) in men rotated through test group beefs low in 
monounsaturated fatty acids (Low MUFA), medium in monounsaturated  
 fatty acids (Mid MUFA), or high in monounsaturated fatty acids  
 (High MUFA) ............................................................................................ 42 
 
 4 Changes from baseline in total cholesterol, LDL, and HDL cholesterol 
concentration (mmol/L) of women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA) or high in monounsaturated  
  fatty acids (High MUFA)............................................................................ 57 
 
 5 Changes from baseline in triglycerides (TAG), intermediate density 
  lipoprotein (IDL), very low density lipoprotein (VLDL), and remnant 
lipoprotein (RLP) cholesterol concentration (mmol/L) of women rotated 
through test ground beefs low in monounsaturated fatty acids (Low  
  MUFA) or high in monounsaturated fatty acids (High MUFA)................. 58 
 
 6 Changes from baseline in LDL III, LDL IV, and Lp(a) cholesterol  
  concentration (mmol/L) of women rotated through test ground beefs  
  low in monounsaturated fatty acids (Low MUFA) or high in  
  monounsaturated fatty acids (High MUFA) ............................................... 60 
 
 7  Changes from baseline in HDL subfractions cholesterol concentrations 
  (mmol/L) of women rotated through test ground beefs low in  
  monounsaturated fatty acids (Low MUFA) or high in monounsaturated  
  fatty acids (High MUFA)............................................................................ 61 
 
 
 
 
 x
FIGURE                                                                                                                         Page 
 
8 Changes from baseline in VLDL and RLP particle concentration (nmol/L) 
  of women rotated through test ground beefs low in monounsaturated fatty  
 acids (Low MUFA) or high in monounsaturated fatty acids  
 (High MUFA) ............................................................................................ 63 
 
9 Changes from baseline in LDL subfraction particle concentration (nmol/L) 
 of women rotated through test ground beefs low in monounsaturated fatty  
 acids (Low MUFA) or high in monounsaturated fatty acids  
 (High MUFA) ............................................................................................ 65 
 
10 Changes from baseline in HDL particle concentration (nmol/L) of women 
rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA) or high in monounsaturated fatty acids (High MUFA) ................ 67 
 
11 Changes from baseline in major plasma fatty acids of women rotated  
 through test ground beefs low in monounsaturated fatty acids (Low  
 MUFA) or high in monounsaturated fatty acids (High MUFA) ................ 70 
 
12 Changes from baseline in long chain plasma fatty acids of women rotated 
through test ground beefs low in monounsaturated fatty acids (Low  
 MUFA) or high in monounsaturated fatty acids  
 (High MUFA) ............................................................................................ 71 
 
13 Changes from baseline in trans plasma fatty acids of women rotated  
 through test ground beefs low in monounsaturated fatty acids (Low  
 MUFA) or high in monounsaturated fatty acids (High MUFA) ................ 72 
 
14 Changes from baseline in cholesterol (mmol/L) in response to a single  
 exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty 
 acids (High MUFA), or habitual diet (Washout) ....................................... 88  
 
15 Changes from baseline in cholesterol (mmol/L) when adjusted for plasma 
volume shifts of women in response to a single exercise session as the  
 women rotated through test ground beefs low in monounsaturated fatty  
 acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
 or habitual diet (Washout) ......................................................................... 89 
 
 
 
 
 
 
 
 
 xi
FIGURE                                                                                                                         Page 
 
 16 Changes from baseline in triglycerides (TAG), intermediate density 
lipoprotein (IDL), very low density lipoprotein (VLDL), and remnant 
lipoprotein (RLP) cholesterol concentration (mmol/L) of women in  
response to a single exercise session as the women rotated through test  
ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet  
(Washout) ................................................................................................... 91 
 
 17 Changes from baseline in triglycerides (TAG), intermediate density 
 lipoprotein (IDL), very low density lipoprotein (VLDL), and remnant 
lipoprotein (RLP) cholesterol concentration (mmol/L) when adjusted for  
 plasma volume shift of women in response to a single exercise session as  
 the women rotated through test ground beefs low in monounsaturated fatty  
 acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
 or habitual diet (Washout) ......................................................................... 93 
 
 18 Changes from baseline in LDL subfraction cholesterol concentrations  
 (mmol/L) of women in response to a single exercise session as the women 
rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA), high in monounsaturated fatty acids (High MUFA), or habitual  
 diet (Washout) ............................................................................................ 95 
 
 19 Changes from baseline in LDL subfraction cholesterol concentrations  
 (mmol/L) when adjusted for plasma volume shift of women in response to 
 a single exercise session as the women rotated through test ground beefs  
 low in monounsaturated fatty acids (Low MUFA), high in  
 monounsaturated fatty acids (High MUFA), or habitual diet  
 (Washout) ................................................................................................... 96 
 
 20 Changes from baseline in HDL subfraction cholesterol concentrations  
 (mmol/L) of women in response to a single exercise session as the women 
rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA), high in monounsaturated fatty acids (High MUFA), or habitual  
 diet (Washout) ............................................................................................ 98 
 
 21 Changes from baseline in HDL subfraction cholesterol concentrations 
 (mmol/L) when adjusted for plasma volume shift of women in response to 
 a single exercise session as the women rotated through test ground beefs  
 low in monounsaturated fatty acids (Low MUFA), high in  
 monounsaturated fatty acids (High MUFA), or habitual diet  
 (Washout) ................................................................................................... 99 
 
 
 
 
 xii
FIGURE                                                                                                                         Page 
 
22 Changes from baseline in VLDL and RLP particle concentrations  
 (nmol/L) in response to a single exercise session as the women rotated  
 through test ground beefs low in monounsaturated fatty acids  
 (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
 or habitual diet (Washout) ......................................................................... 101 
 
23 Changes from baseline in VLDL and RLP particle concentrations  
 (nmol/L) when adjusted for plasma volume shifts in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated  
 fatty acids (High MUFA), or habitual diet (Washout) ............................... 102 
 
24 Changes from baseline in LDL subfraction particle concentrations  
 (nmol/L) in response to a single exercise session as the women rotated 
 through test ground beefs low in monounsaturated fatty acids  
 (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
 or habitual diet (Washout) ......................................................................... 104 
 
25 Changes from baseline in LDL subfraction particle concentration  
 (nmol/L) when adjusted for plasma volume shifts in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated  
 fatty acids (High MUFA), or habitual diet (Washout) ............................... 105 
 
26 Changes from baseline in HDL lipoprotein particle concentration  
 (nmol/L) in response to a single exercise session as the women rotated  
 through test ground beefs low in monounsaturated fatty acids  
 (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
 or habitual diet (Washout) ......................................................................... 107 
 
27 Changes from baseline in HDL lipoprotein particle concentration  
 (nmol/L) when adjusted for plasma volume in response to a single  
 exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated  
 fatty acids (High MUFA), or habitual diet (Washout) ............................... 108 
 
28 Changes from baseline in major plasma fatty acids in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty 
 acids (High MUFA), or habitual diet (Washout) ....................................... 113 
 
 
 
 
 
 xiii
FIGURE                                                                                                                         Page 
 
29 Change from baseline in trans plasma fatty acids in response to a 
 single exercise session as the women rotated through test ground beefs  
 low in monounsaturated fatty acids (Low MUFA), high in  
 monounsaturated fatty acids (High MUFA), or habitual diet  
 (Washout) ................................................................................................... 114 
 
 
 
  
 
 
 
 
 
 
 
 xiv
LIST OF TABLES 
 
TABLE                                                                                                                           Page 
 1 Production and carcass characteristics of Angus steers used to produce  
  the test ground beef..................................................................................... 29 
 
 2 Fatty acid composition of low MUFA, mid MUFA, and high MUFA  
  ground beef ................................................................................................. 31 
 
 3 Daily intake of major nutrients for habitual diets and for test diets of men 
rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA), medium in monounsaturated fatty acids (Mid MUFA), or high in 
monounsaturated fatty acids (High MUFA) .............................................. 34 
 
 4 Dietary exchanges for habitual diets and for test diets of men rotated  
  through test ground beefs low in monounsaturated fatty acids  
  (Low MUFA), medium in monounsaturated fatty acids (Mid MUFA),  
  or high in monounsaturated fatty acids (High MUFA) .............................. 35 
 
 5 Initial and final characteristics of men rotated through ground beef types  
  low in monounsaturated fatty acids, medium in monounsaturated fatty  
  acids, or high in monounsaturated fatty acids (pooled across dietary 
interventions). ............................................................................................. 36 
  
 6  Initial and final plasma fatty acids of men rotated through ground beef  
  types low in monounsaturated fatty acids, medium in monounsaturated  
  fatty acids, or high in monounsaturated fatty acids (pooled across dietary 
interventions) ............................................................................................. 38 
 
 7 Baseline characteristics for subjects ........................................................... 51 
 
 8 Fatty acid composition of low MUFA and high MUFA 
  ground beef patties...................................................................................... 52 
 
 9 Total daily energy intake from major nutrients for habitual diets  
  (Baseline) and for test diets of women rotated through test ground beefs  
  low in monounsaturated fatty acids (Low MUFA) or high in  
  monounsaturated fatty acids (High MUFA). .............................................. 55 
  
 10 Major lipoprotein cholesterol concentrations (mmol/L) for women rotated 
through test ground beefs low in monounsaturated fatty acids (Low MUFA)  
  or high in monounsaturated fatty acids (High MUFA)............................... 56 
 
 
 xv
TABLE                                                                                                                           Page 
 11 TAG, VLDL, RLP, and IDL cholesterol concentrations for women rotated 
through test ground beefs low in monounsaturated fatty acids (Low MUFA) 
  or high in monounsaturated fatty acids (High MUFA)............................... 59 
 
 12 LDL III, LDL IV, and Lp(a) lipoprotein cholesterol concentrations for  
  women rotated through test ground beefs low in monounsaturated fatty  
  acids (Low MUFA) or high in monounsaturated fatty acids  
  (High MUFA) ............................................................................................. 59 
 
 13 HDL subfraction cholesterol concentrations for women rotated through test 
ground beefs low in monounsaturated fatty acids (Low MUFA) or high in 
monounsaturated fatty acids (High MUFA) .............................................. 62 
  
 14 VLDL and RLP particle concentrations for women rotated through test 
  ground beefs low in monounsaturated fatty acids (Low MUFA) or high in 
monounsaturated fatty acids (High MUFA) .............................................. 64 
 
 15 LDL and LDL subfraction particle concentrations for women rotated  
  through test ground beefs low in monounsaturated fatty acids (Low MUFA) 
  or high in monounsaturated fatty acids (High MUFA) .............................. 66 
 
 16 HDL particle concentrations for women rotated through test ground beefs 
  low in monounsaturated fatty acids (Low MUFA) or high in  
  monounsaturated fatty acids (High MUFA) .............................................. 68 
 
 17 C-reactive protein, homocysteine, and insulin levels pre- and post-test patty 
consumption ............................................................................................... 68 
 
 18 Particle density and size pre- and post-test patty consumption ................. 69 
 
 19 Plasma fatty acid concentrations (g/100 g fatty acids) of women rotated  
  through test ground beefs low in monounsaturated fatty acids (Low MUFA)  
  or high in monounsaturated fatty acids (High MUFA) .............................. 73 
 
 20 Simple correlations between plasma fatty acids and cholesterol fractions,  
  triglycerides, hs-CRP, insulin, and homocysteine ...................................... 76 
 
 21 Simple correlations between plasma fatty acids and cholesterol  
  subfractions, HDL mean density, LDL particle size and density ............... 77 
 
 22 Percent energy from fat, carbohydrate, and protein.................................... 85 
 
 
 
 
 xvi
TABLE                                                                                                                           Page 
23 Average energy expenditure and exercise duration with each bout of  
  exercise ....................................................................................................... 86 
 
 24 Plasma volume shifts due to exercise ......................................................... 86 
 
 25 Average energy expenditure per day estimated from self reported 7-d  
  activity records for each study phase .......................................................... 87 
  
 26 Cholesterol concentrations in response to a single exercise session as the  
  women rotated through test ground beefs low in monounsaturated fatty 
  acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
  or habitual diet (Washout) ......................................................................... 87 
 
 27 TAG, VLDL, RLP, and IDL cholesterol concentrations of women in  
  response to a single exercise session as the women rotated through test  
  ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet  
  (Washout) ................................................................................................... 92 
 
 28 LDL subfraction cholesterol concentrations of women in response to a  
  single exercise session as the women rotated through test ground beefs low 
  in monounsaturated fatty acids (Low MUFA), high in monounsaturated  
  fatty acids (High MUFA), or habitual diet (Washout) ............................... 94 
 
 29 HDL subfraction cholesterol concentrations of women in response to a  
  single exercise session as the women rotated through test ground beefs low  
  in monounsaturated fatty acids (Low MUFA), high in monounsaturated  
  fatty acids (High MUFA), or habitual diet (Washout) ............................... 97 
 
 30 VLDL and RLP particle concentrations of women in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty  
  acids (High MUFA), or habitual diet (Washout) ....................................... 100 
 
 31 LDL particle concentrations in response to a single exercise  
  session as the women rotated through test ground beefs low in  
  monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty  
  acids (High MUFA), or habitual diet (Washout) ....................................... 103 
 
 32 HDL particle concentrations in response to a single exercise session as the 
women rotated through test ground beefs low in monounsaturated fatty  
  acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
  or habitual diet (Washout) ......................................................................... 106 
 
 
 xvii
TABLE                                                                                                                           Page 
 33 C-reactive protein, homocysteine, and insulin levels in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated  
  fatty acids (High MUFA), or habitual diet (Washout) ............................... 109 
 
 34 Particle density and size in response to a single exercise session as the  
  women rotated through test ground beefs low in monounsaturated fatty  
  acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
  or habitual diet (Washout) ......................................................................... 110  
 
 35 Plasma fatty acid levels in response to a single exercise session as the  
  women rotated through test ground beefs low in monounsaturated fatty  
  acids (Low MUFA), high in monounsaturated fatty acids (High MUFA),  
  or habitual diet (Washout) ......................................................................... 111 
 
 36 Overall effects of MUFA:SFA ratio of ground beef on major cholesterol 
fractions and triglycerides........................................................................... 119 
 
 
 
 
 
  
 
  
  
 
 
 
 
 
 
  
 
 
 
 
 
 1
CHAPTER I 
INTRODUCTION 
 
Introduction  
Cardiovascular disease (CVD), a multifaceted disorder, is the leading cause of 
death in the United States. Atherosclerosis is the major contributor to CVD and has been 
plaguing the human race for centuries with early cases being seen in Egyptian mummies 
(1).  Galkina and Ley (2) defined atherosclerosis as a chronic inflammatory process 
characterized by plaque formation within the vessel wall of arteries and extensive 
necrosis and fibrosis of surrounding tissues.  Being chronic, this disease process 
progresses over time. The progression of CVD begins with an imbalance of endothelial 
function, lipid metabolism, and lipid retention. Ross (3) summarized the theory that 
attributed the initiation of endothelial dysfunction to a response to injury whether it be 
mechanical injury, toxins, or oxygen radicals. The first visible lesions of atherosclerosis 
are foam cells, which with lymphocytes form fatty streaks that consist of lipid-rich 
macrophages and T cells within a thin layer of lipid on the arterial wall. Fatty streaks are 
formed as a response to the disruption of normal endothelial cell function. The plaque 
formation and immune response are self-propagating. As the fatty streaks are formed, 
macrophages are recruited, surround the lipid, and become activated foam cells.  
____________ 
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Many inflammatory molecules, including cytokines, are released by the foam cells which 
in turn attract more lymphocytes, intensifying the immune response. This perpetuation 
results in a plaque with a fatty core covered by a stabilizing fibrous matrix (4). 
 
Inflammation and CVD 
 Inflammation plays an integral role in the initiation and progression of CVD (5).  
Inflammation is also seen with conditions such as obesity, insulin resistance, 
hypertension, metabolic syndrome, type 2 diabetes, hypertriglyceridemia, low HDL 
cholesterol and smoking, all of which are correlated with increased CVD risk (6). For this 
reason, inflammatory proteins such as high sensitivity C-reactive protein (hs-CRP), 
interleukin-6 (IL-6), and serum amyloid A (SAA), when elevated chronically, are 
considered markers of CVD (7, 8). hs-CRP and SAA are acute-phase proteins which 
become elevated as an innate immune response during periods of infection, 
inflammation, and tissue damage. After an innate response is initiated, the adaptive 
immune system is activated with B- and T-cell responses such as production of IL-6 (9). 
Unlike hs-CRP which travels freely in the plasma, SAA is an apolipoprotein primarily 
associated with HDL particles. SAA levels also have been correlated to the incidence of 
CVD (6). Inflammation markers are important predictors of cardiovascular events in 
women (8).  
Homocysteine is not an inflammatory protein, but it is regarded as a biomarker 
strongly associated with CVD. A single mechanism by which homocysteine contributes 
to CVD is not established. Homocysteine may cause endothelial damage and dysfunction 
by affecting nitric oxide production and reactivity (10). With all the biomarkers, a 
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multimarker approach that may be predictive of cardiovascular events should be utilized 
(11). 
 
Lipoprotein Metabolism 
The particles responsible for the packaging and transport of lipid-soluble 
constituents in an aqueous environment are lipoproteins. The main goal of lipoprotein 
metabolism is to package and transport cholesterol and lipids from the liver to 
extrahepatic tissues and then back to the liver. Lipoproteins are classified into five main 
groups based on particle density: high-density lipoproteins (HDL), low density 
lipoproteins (LDL), intermediate density lipoproteins (IDL), very low density 
lipoproteins (VLDL), and chylomicrons. Lipoproteins also can be grouped according to 
surface charge as “alpha” or “beta.” Each lipoprotein class is responsible for specific 
activities related to lipoprotein metabolism. 
  
High Density Lipoproteins 
High density lipoproteins, as a class of lipoproteins, are a heterogeneous mix of 
HDL subfractions. These subfractions can be characterized and sorted by density, size, 
shape, apolipoprotein composition and surface charge. When separated by size and 
density, HDL are classified as, HDL2b, HDL2a, HDL3a, HDL3b and HDL3c. Based on 
apolipoprotein composition, HDL can be divided into subpopulations A-I HDL which 
contain apoA-I but no apoA-II, and A-I/A-II HDL, which contain both apoA-I and apoA-
II. Agarose gel electrophoresis separates HDL based on surface charge. HDL are then 
classified as alpha, pre-alpha, pre-beta or gamma based on migration relative to the 
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plasma proteins. The surface charge then influences particle shape. Alpha HDL contain 
both apoA-I and apoA-II and are spherical lipoproteins whereas pre-beta HDLs are lipid-
poor apoA-1 discoidal particles. HDL particles are not limited to one characteristic, but 
can bear characteristics of each category (12).  
HDL cholesterol is well known as the “good’ cholesterol. This is due in part to its 
role in reverse cholesterol transport, which is the means in which cholesterol is removed 
from the peripheral tissues, including the macrophages in vessel walls. Reverse 
cholesterol transport is one of the major defense mechanisms against the development of 
atherosclerosis. Many enzymes are involved in reverse cholesterol transport, including 
lecithin cholesterol acyltransferase (LCAT) which transesterifies the sn-2 or sn-1 fatty 
acid of a phosphatidyl-choline molecule to the 3-β-hydroxyl group of cholesterol, 
resulting in a cholesterol ester and lysophosphatidyl-choline. LCAT is primarily 
associated with HDL and plays a major role in HDL metabolism. HDL formation begins 
with an apoA-1 and nascent HDL aggregate. The LCAT reaction is used to fill the 
nascent HDL with cholesterol ester, forming HDL3 and then the larger HDL2. HDL2 
cholesterol then can be taken up by the liver via scavenger receptor class B member 1 
(SR-B1). If LCAT activity is decreased, mature HDL production also is decreased. Like 
many mechanisms in the body, cholesterol efflux depends in part on a gradient. By 
esterifying fatty acids to free cholesterol and creating more cholesterol ester, which is 
then packaged into lipoproteins, LCAT helps maintain the cholesterol gradient favorable 
for the diffusion of free cholesterol from the peripheral tissues to HDL.  
Other enzymes important in reverse cholesterol transport include cholesteryl ester 
transfer protein (CETP) and hepatic lipase. CETP facilitates the exchange of cholesterol 
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ester from HDL for triglyceride in apoB100-containg lipoproteins such as LDL. 
Cholesterol esters removed in this way can be taken up by the liver by the LDL receptor. 
A decrease in CETP activity may increase HDL cholesterol concentrations and decrease 
VLDL and LDL cholesterol concentrations. However, the relationship of CETP to CVD 
(atherogenic or antiatherogenic) is still controversial (13). Hepatic lipase is responsible 
for hydrolyzing triglycerides and phospholipids in lipoproteins. 
Cholesterol can be removed from the macrophages found in vessel walls through 
many independent pathways involving ATP-binding membrane cassette transport protein 
AI (ABCA1),  SR-B1, caveolins, sterol 27-hydroxylase, and passive diffusion (14). 
ABCA1-mediated cholesterol efflux correlates positively with pre-β-1 HDL levels, 
whereas SR-B1 selectively removes cholesterol from HDLα-1 particles and correlates 
positively with HDLα-1 and α-2 particle levels (15, 16). Whereas ABCA1 mediates 
cholesterol efflux to preβ-HDL (17), ABCG1 stimulates efflux to larger HDL particles, 
especially HDL2 (18). 
HDL cholesterol is also beneficial in preventing CVD due to its antioxidant 
properties through the enzyme paraoxonase. Paraoxonase, though not directly involved in 
reverse cholesterol transport, is an HDL-bound enzyme that hydrolyzes oxidized lipids in 
LDL and HDL particles. If not hydrolyzed, these oxidized lipids may impair endothelial 
function (19). Platelet-activating factor acetyl hydrolase and LCAT are also HDL-
associated enzymes that are able to remove oxidized phospholipids (20).  Apo A-I acts as 
an antioxidant as well by removing oxidized lipids from LDL and possibly undergoing 
oxidative modification in return (21). 
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Bérard et al. (22) has shown that through regulation of the many enzymes 
involved in reverse cholesterol transport, fatty acids are able to influence HDL 
cholesterol concentration and functionality. HDL level alone may not dictate the level of 
CVD risk (22). Demonstrating HDL subfractions and functionality has become more 
important than HDL cholesterol. The HDL subpopulation profile of CVD patients with 
low total HDL cholesterol levels has significantly less large cholesterol-rich HDL and 
more small lipid depleted particle levels than patients with no cardiovascular event (23). 
The functionality of each HDL subclass still is equivocal. Low proportions of 
large HDL2b particles and high proportions of small HDL particles has been associated 
with other CVD risk factors such as increased body mass index (BMI), hyperinsulinemia, 
hypertriglyceridemia, increased visceral adipose tissue, increased homeostatic model 
assessment of insulin resistance (HOMA-IR) scores, and increased carotid intima-media 
thickness (IMT) (24-28).  Although the correlation between high proportions of small, 
dense HDL and CVD is strong, some argue that small, dense HDL particles are more 
functional and protective against CVD. In an in-vitro system, at similar physiological 
concentration and circulating levels, HDL antioxidant activity increased in the order 
HDL2b<HDL2a<HDL3c<HDL3b<HDL3a. When HDL particles were studied in equal 
number (not representative of physiological conditions) antioxidant activity increased in 
the order HDL2b<HDL2a<HDL3a<HDL3b<HDL3c, with the antioxidant activity of HDL3c 
most effective at the late stages of oxidation (29).  
Together these findings indicate that small dense HDL particles protect LDL 
against oxidative stress and HDL antioxidative activity is dependent, in part, on the 
concentration of the particle (29). Along with high antioxidative activity, small HDL are 
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better cholesterol acceptors and have a high capacity to inhibit expression of adhesion 
molecules in patients with low total HDL concentrations (30, 31). However, the 
antioxidative activity of small, dense HDL, especially HDL3b and HDL3c, is impaired in 
patients with metabolic syndrome and established coronary artery disease (32). Oxidative 
damage can impair the ability of apoA1 to remove cholesterol from macrophages (33). 
During an inflammatory state, HDL has been shown to be proatherogenic, being depleted 
of specific proteins such as apo-A1, apo-AII, and paraoxonase while becoming enriched 
in SAA. SAA incorporation into HDL may inhibit its ability to deliver free cholesterol to 
the liver for clearance. Though the HDL cholesterol will rise, the antioxidant function of 
HDL will decrease (34). 
 
Very Low Density Lipoproteins 
VLDL are thought to be the first lipoprotein synthesized by the liver in the 
sequence of lipoprotein metabolism. When secreted, VLDL are large triglyceride-rich 
particles and contain apoB100. Once in circulation, VLDL acquire apoE and apoC (I,II, 
and II). VLDL are delipidated by lipoprotein lipase, which is found on the surface of 
extrahepatic tissues. As VLDL triglycerides are hydrolyzed, the cholesterol, 
phospholipids, and proteins are transferred to higher density lipoproteins such as HDL 
and LDL, leaving a small, dense remnant lipoprotein (RLP). RLP are further metabolized 
to smaller more dense lipoproteins called IDL, which are remodeled to form the 
endproduct LDL. Due to the retention of apoB-100, both IDL and LDL can be cleared 
from the plasma by the LDL receptor, which has a high affinity for apoB-100 and apoE 
(35, 36). The clearance of lipoprotein particles by the LDL receptor is down-regulated 
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when the need for cholesterol by the peripheral cells is met, which suggests accumulation 
of LDL, IDL, RLP by arterial foam cells may not be mediated by the LDL receptor (37). 
This idea has been supported with the characterization of the scavenger receptor, which is 
found on the surface of macrophages and endothelial cells and facilitates the uptake of 
lipoproteins such as modified LDL, IDL, and RLP particles, but not native LDL particles 
(38).  Hyperinsulinemia and increased free fatty acids secondary to insulin resistance lead 
to an increase in plasma triglycerides and VLDL concentrations. Although VLDL and 
triglycerides correlate strongly to LDL density and decreasing LDL size, these 
characteristics are inversely related to HDL cholesterol, especially the HDL2 subfraction 
(39, 40). 
 
Low Density Lipoproteins  
The National Cholesterol Education Program defines the desirable LDL 
cholesterol concentration as <3.62 mmol/L (41). Like HDL, LDL are heterogeneous and 
can be defined on the basis of particle density, size, charge and chemical composition. 
LDL particles are commonly separated by density ultracentrifugation, resulting in LDL I 
through IV, with LDL IV being the most dense (42). LDL concentration, particle size and 
density are influenced by age, gender, hormone replacement therapy or contraceptive use, 
abdominal adiposity, diet and exercise. Small, dense LDL particles with increased 
triglycerides and low HDL cholesterol are often associated with metabolic syndrome and 
diabetes mellitus secondary to insulin resistance (43). Though there is much colinearity 
between the CVD risk factors, it is still believed that small, dense LDL particles are a 
contributing factor to atherosclerosis based on evidence that smaller LDL are taken up 
 
 9
less readily by LDL receptors (44), are more apt to penetrate arterial tissue (45) and are 
oxidized at a greater rate than larger LDL particles (46). Some argue that it is not particle 
size or amount of cholesterol carried alone that matters, but the particle number as well 
(47, 48). LDL cholesterol concentration can be the same among individuals, but particle 
number can vary greatly. Cromwell and Otvos (47) suggest LDL particle numbers be 
used instead of LDL cholesterol concentrations to better assess risk for CVD. 
 As stated previously, macrophages and endothelial cells specialize in the uptake 
of modified LDL particles, which leads to the progression of atherogenesis. LDL 
particles may be modified in a number of different ways, including acetylation, 
malondialdehyde addition, acetoecetylation, carbamylation, LDL-dextran sulfate 
complex formation, oxidation, glycation and desialylation, but not all modifications lead 
to increased uptake by the scavenger receptor. Oxidation of LDL particles may be the 
most studied mechanism in which LDL particles are modified and lead to increased 
uptake by the scavenger receptor. Oxidation of the LDL can occur through phospholipid 
oxidation (mainly phosphatidycholine), which then propagates into the core of the LDL 
particle, with cholesterol and cholesterol ester oxidation and fragmentation of Apo B. It is 
the fragmentation and change in amino acid sequence of the Apo B that is thought to be 
responsible in a shift from particle recognition from the LDL receptor to the scavenger 
receptor (49). Therefore quantifying LDL cholesterol levels alone can be misleading for 
assessing CVD risk (50). 
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Lipoprotein(a) (Lp(a))  
Lp(a) is similar to LDL particles, but also contains apolipoprotein(a). Because of 
the apo(a), Lp(a) is not taken up by the LDL receptor and in return Lp(a) levels are 
dependent on genetically regulated synthesis and not particle clearance. Lp(a) is a strong 
risk factor of CVD; because  Lp(a) particles accumulate in atherosclerotic lesions, Lp(a) 
levels correlate positively with CVD associated events, Lp(a) is both proatherogenic and 
prothrombotic and Lp(a) is thought to be the main scavenger of oxidized phospholipids 
(51-53).  
 
Plasma Fatty Acids and CVD 
 Plasma fatty acids can be obtained directly from the diet (exogenously) or from 
fatty acids synthesized or modified by metabolic pathways in the body (endogenously). 
Fatty acids can impact metabolism by up- or down- regulating enzymes. Though it is 
difficult with nonessential fatty acids to distinguish endogenous from exogenous fatty 
acids, their origin may dictate their impact on metabolism. For example, dietary oleic 
acid has been shown to have positive health benefits (54), but for oleic acid synthesized 
by hepatic stearoyl-CoA desaturase (SCD1), negative health effects are seen such as 
increased plasma triglycerides, decreased HDL, increased VLDL, and increased LDL 
(55). SCD1 is a delta-9-desaturase responsible for placing a double bond at carbon 9 of a 
fatty acid chain. The most common substrates for SCD1 are stearic acid and palmitic 
acid. Desaturation by SCD1 results in oleic (18:1(n-9)) and palmitoleic acid (16:1(n-7)), 
respectively (56).  SCD1-deficient mice are protected from insulin resistance, diet-
induced obesity, increase triglycerides, and increased VLDL (57). Many of the effects of 
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SCD1 deficiency are dependent on diet composition and other genetic factors (58).  
Though it seems SCD1 deficiency is antiatherogenic, SCD1 deficiency also promotes 
inflammation and atherosclerosis in mice (59). When increased SCD1 activity is seen in 
macrophages, palmitoleic acid is increased and relief from lipid-induced endoplasmic 
reticulum (ER) stress is provided. Erbay et al. (60) demonstrated endogenous fatty acid 
synthesis and desaturation of fatty acids can be highly beneficial for defending ER 
function when macrophages are exposed to toxic lipids, which may lead to an 
antiatherogenic effect of SCD1 activity. 
 
Menopausal Status and CVD 
 Menopause brings on many changes, one of which is increased risk for CVD. 
This increased risk is due in part to reduced circulating estrogen and an overall reduction 
in physical activity. Although women have higher HDL and total cholesterol and lower 
LDL cholesterol and triglycerides than men (61), HDL cholesterol levels decrease in 
women after menopause. The decrease in HDL is accompanied by an increase in LDL, 
total cholesterol, VLDL, triglycerides, glucose and BMI after menopause, contributing to 
an increased risk for CVD (62-64). HDL changes in postmenopausal women are 
accompanied by more dense, smaller HDL particles (64). Though postmenopausal 
women have different lipid profiles than premenopausal women, the changes in their 
profile as a response to exercise is the same (63). When estrogen is replaced in 
postmenopausal women in a combination with exercise, HDL lipid peroxidation is 
reduced (65). 
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Dietary Influence on CVD 
 It is well known that CVD can be influenced favorably by diet and exercise, but 
optimal dietary content continues to be debated. The National Cholesterol Education 
Program/American Heart Association Step I or Step II previously recommended a diet 
low in total fat, especially saturated fat (8-10% and < 7% of energy, respectively), and 
cholesterol was kept below 300 or 200 mg/d, respectively. At that time, carbohydrate was 
used to replace saturated fat. Though low in total fat, the high-carbohydrate diet increased 
plasma triglyceride concentrations and decreased HDL cholesterol concentrations, 
although beneficial effects were seen for total and LDL cholesterol (41, 66). Though a 
reduction was seen in total LDL concentration, which is thought to be beneficial, Campos 
et al. (67) reported an associated reduction of LDL particle size with reduced animal fat 
intake and increased consumption of carbohydrates. LDL:HDL ratios are reduced when 
carbohydrate is replaced with fat, even with saturated fat (68). When isocaloric 
substitutions of carbohydrates for monounsaturated fat or polyunsaturated fat were made 
in the diets of women, their risk of CVD increased 20 and 60%, respectively (69). 
Changing the quality of the fat in the diet has been shown to be more beneficial than 
reducing the total amount of fat in the diet (68, 69). High-carbohydrate diets also increase 
Lp(a) concentrations (70). In the year 2000, the Nutrition Committee of the American 
Heart Association moved away from its former insistence on low-fat diets and concluded 
that diets that provided up to 40% of dietary energy in the form of unsaturated fat were as 
heart-healthy as low-fat diets. An outcome of this official opinion has been the 
reevaluation of the nutritional properties of a number of higher fat foods such as dairy, 
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nuts, and dietary oils such as olive oil rich in the monounsaturated fatty acid, oleic acid 
(71).  
Fatty acids are not only sources of energy, but are powerful modulators of cell 
function and gene transcription. By this, fatty acids modulate metabolic and 
inflammatory response by the body (72). Differences in fatty acid chain length and 
saturation/unsaturation account for the differences in biological effects and physical 
properties. Kris-Etherton et al. (73) performed a meta-analysis which showed the varying 
effect of individual fatty acids on total cholesterol, LDL, and HDL cholesterol. It was 
clear that individual fatty acids have different effects on serum cholesterol fraction even 
if they belong to the same class of lipid, saturated, unsaturated, or trans-fats (73). Though 
types of fats and higher fat foods have been reevaluated and are now considered “heart 
healthy,” the American Heart Association discourages the consumption of red meat due 
to its saturated fat content. 
 Due to the current recommendations, beef and beef fat and their effects on CVD 
have been examined closely. Though beef fat and coconut oil are both considered to be 
high in saturated fat, they do not have the same effects on cholesterol levels. When 
compared to coconut oil, which consist of more medium chain saturated fatty acids 
(lauric (12:0) and myristic acid (14:0)), beef fat reduced total, LDL, and HDL cholesterol 
(74). When red meat was tested against fish and poultry, there were no significant 
difference in plasma cholesterol concentrations between the diets consisting of red meat, 
fish or poultry (75). 
Numerous clinical and epidemiological studies have shown saturated fats have 
adverse effects on cholesterol metabolism and thus increase the risk of CVD (76). Using 
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regression analysis, Keys et al. (77) and Hegsted et al. (78) evaluated the effect of 
individual fatty acid classes on cholesterol concentration in humans. Their equations 
estimated that saturated fat is twice as potent in raising total cholesterol as 
polyunsaturated fats are in reducing it. Mazaffarian et al. (79) found while eating a low 
fat diet (25% energy), a greater saturated fat intake (10-16% energy) was associated with 
less progression of coronary atherosclerosis in postmenopausal women than a lower 
intake of saturated fat (3-7% energy). There could be many reasons why this study does 
not support the general trend of saturated fat effects, including participant characteristics, 
other dietary components including carbohydrates, and individual saturated fatty acids 
consumed. 
 
Saturated Fats  
Stearic acid (18:0) is the second most abundant saturated fatty acid in beef and 
accounts for 13-20% of total fatty acids (80). Although saturated fats have been 
positively correlated with CVD, stearic acid has been shown to have neutral effect on 
lipids and lipoproteins. This has been shown by predictive equations and through 
replacing carbohydrate with stearic acid in the diet (81, 82). The regression analysis of 
Muller et al. (81) demonstrated that stearic acid had no effect on total cholesterol, LDL 
cholesterol or HDL cholesterol concentrations compared to myristic, lauric or palmitic 
acid (16:0). When stearic acid was substituted for lauric, myristic and palmitic acid, it 
lowered total, LDL and HDL cholesterol (68). Watts et al. (83) questioned the influence 
of stearic acid on CVD through a prothrombotic effect independent of plasma cholesterol 
concentration. A prothrombic effect was seen in hypercholesterolemic men with a 
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previous occurrence of angina pectoris or myocardial infarction when the usual diet was 
consumed, which was higher in stearic acid than the test diet. Although a prothrombic 
effect was observed, the usual diet was higher in other fatty acids, cholesterol, energy, 
total fat, saturated fat and monounsaturated fat and trans-fat than the test diet. The data 
provided by the angiogram could not specifically be attributed to stearic acid. Stearic acid 
also has less of an influence on postprandial lipemia and thus the activation of thrombotic 
factors than oleic, elaidic (18:1trans-9), and palmitic acids (84). 
Whereas stearic acid is neutral in its effects on cholesterol metabolism, palmitic 
acid has a negative effect. Palmitic acid is the main saturated fatty acid found in beef (24-
25% of all fatty acids) (80). Evidence from metabolic ward studies and epidemiological 
studies have shown that palmitic acid, when compared to unsaturated fatty acids and 
carbohydrates, raises total cholesterol, with the greatest increase in LDL cholesterol, and 
a slight increase in HDL cholesterol and VLDL cholesterol (85). The slight increase in 
HDL cholesterol associated with the intake of palmitic and myristic fatty acids may be 
due to an impairment in reverse cholesterol transport and the residence time of HDL 
particles. HDL may be less capable to return cholesterol to the liver due to a decrease in 
SR-B1 and 7α-hydroxylase activity (86).  Nicholls et al. (87) examined the effect that 
saturated fats have on the anti-inflammatory potential of HDL. After consumption of a 
meal high in saturated fat, HDL was less functional than HDL isolated from fasting 
plasma. The saturated fat diet reduced the ability of HDL to inhibit the expression of 
intercellular adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-
1), possibly by reducing HDL anti-inflammatory properties (88). 
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Monunsaturated Fats 
 When monounsaturated fats were used to replace carbohydrate in an average 
American diet, total cholesterol was reduced by approximately 10% and LDL cholesterol 
by 14% (68). The high-monounsaturated fatty acid diet did not lower HDL cholesterol 
whereas a high-carbohydrate diet (59% of energy) lowered HDL by 4% compared to the 
average American diet (70). Mente et al. (89) used the Bradford Hill Guidelines to 
evaluate the scientific evidence of a causal relationship between each dietary exposure 
and CVD. Through the analysis of cohort data of 101,521 patients, Mente et al. (89) 
found higher consumption of monounsaturated fatty acids was associated with 
significantly lower risk of CVD. Outside of lipid profiles, monounsaturated fatty acids 
are antiatherogenic by decreasing the susceptibility of LDL to oxidation, improving 
endothelial function and reducing inflammation marker levels and platelet aggregation. 
Monounsaturated fatty acids are antihypertensive, and could improve insulin sensitivity 
(90). These findings may be due to, or are enhanced by, minor compounds found in olive 
oil, the common source of monounsaturated fatty acids in study protocols (91). 
Oleic acid is the main monounsaturated fatty acid found in beef (80), but it 
typically is associated with olive oil and the Mediterranean diet. There are polyphenolic 
compounds in olive oil that also have an influence on lipid metabolism, in that they 
reduce  HMG-CoA reductase activity (92). Though Pérez-Jiménez et al. (91) points out 
the beneficial effects of the polyphenols found in olive oil, he does not disregard the 
positive effects of the fatty acids in olive oil, mainly oleic acid, on cholesterol 
metabolism. The effect of olive oil on cholesterol metabolism was confirmed by Ruíz-
Gutiérrez et al. (54). They observed an increase in HDL cholesterol in hypertensive 
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women who consumed a diet enriched with high-oleic sunflower oil or olive oil. 
Additionally, a significant decrease in plasma HDL2 and an increase in plasma HDL3 
cholesterol concentrations were seen with the oleic and interventions. In addition to an 
increase in HDL cholesterol, oleic acid reduces the post-secretory oxidation of LDL 
particles, making them less atherogenic (54). 
 
Polyunsaturated Fats 
 The American Heart Association has moved away from low fat/high carbohydrate 
diets as discussed previously, but what is to replace the carbohydrate? Jakobsen et al. (93) 
suggested substituting polyunsaturated fatty acids for carbohydrate. Less fatal coronary 
heart disease events were seen when polyunsaturated fats, especially linoleic acid 
(18:2(n-6)), were substituted for carbohydrate as compared to saturated fats and even 
monounsaturated fats. A review by Kris-Etherton (94), indicated that intervention studies 
with n-6 polyunsaturated fatty acids obtained a 13-16% reduction in total cholesterol. 
Though a reduction in total cholesterol can be considered beneficial when it comes to 
cardiovascular health, n-6 polyunsaturated fatty acids are known to be proinflammatory, 
increasing the production of cytokines, hs-CRP and SAA levels, and stimulating 
endothelial activation (90). 
 When n-3 polyunsaturated fatty acids are increased in beef, the increase is seen in 
α-linolenic acid (18:3(n-3), ALA) not docosahexaenoic acid (22:6(n-3), DHA), or 
eicosapentaenoic acid (20:5(n-3), EPA). Intervention studies have shown that increased 
intake of EPA and DHA lowers the risk of CVD (95, 96).  For example, supplementation 
of  3 g DHA/d for 45 and 90 d significantly decreased remnant lipoprotein concentrations 
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through a reduction in postprandial triglycerides in hypertriglyceridemic men (97).  
Though humans can convert ALA to EPA and some DHA, the conversion is too limited 
to replace the consumption of DHA and EPA directly from cold water fish. When ALA is 
compared to EPA and DHA in regards to CVD risk factors, Goyens (98) saw that EPA 
and DHA increased LDL cholesterol levels and tissue factor pathway inhibitor activity 
(an inhibitor of blood coagulation).   
 
Trans-Fats 
Over the last two decades, trans-fats and their relation to CVD increasingly have 
been an area of interest. trans-Fats are not metabolically equivalent to the cis-isomers and 
have adverse effects on serum lipid profiles (99). trans-Fats raise LDL cholesterol, lower 
HDL concentrations, increase triglycerides and increase Lp(a) when substituted for 
saturated fat (100). In addition to the reduction of HDL-cholesterol, trans-fats have been 
shown to reduce serum paraoxonase activity (19). 
 Little has been studied concerning individual trans-fatty acids, but several studies 
have been done dividing trans-fats into those from industrial sources, or partially 
hydrogenated oils, and those from ruminant animals as a result of biohydrogenation of 
fatty acids by rumen bacteria. Epidemiologic studies have shown a positive association 
between CVD risk and the intake of trans-fat from industrial sources, but not between 
CVD risk and ruminal trans-fats (101). These epidemiological data have lead to multiple 
intervention studies which have supported past data. Motard-Bélanger et al. (102) showed 
high intakes (10.2 g/2,500 kcal) of both industrial and ruminal trans-fats, significantly 
increased LDL cholesterol concentrations and reduced HDL cholesterol. Whereas high 
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intake of ruminal trans-fat leads to deleterious changes in cholesterol homeostasis, 
moderate intake (4.2 g/2,500 kcal) had no effects. Compared to industrial trans-fats, 
ruminal trans-fats significantly increased large HDL and LDL concentrations (103).  
Mozaffarian (104) reported that consuming trans-fats not only influences 
lipoprotein concentrations, but also is associated with higher circulating markers of 
systemic inflammation, including TNF-α, IL-6 and hs-CRP. When mononuclear cells 
from hypercholesterolemic subjects were cultured, increased production of IL-6 and 
TNF-α was seen with a soybean margarine diet (6.7% energy from trans-fats), compared 
with a soybean oil diet (0.6% energy from trans-fats) (105). When using cow feeding 
strategies to increase the vaccenic acid (18:1(trans-11)) concentration in milk fat, 
Tholstrupt (106) did not see a significant difference between the butter made with high-
vaccenic milk and a control diet in their effects on hs-CRP concentrations, urinary 
excretion of PGF2α, or other hemostatic risk and oxidative stress markers. There also was 
a reduction in total and HDL cholesterol levels. This may have been due in part to the 
method in which the high vaccenic butter was made. Through vaccenic acid was 
increased by the feeding method, so was conjugated linoleic acid, oleic acid and stearic 
acid, with a decrease in palmitic and myristic acid. This profile may reflect the actual 
consumption of products containing ruminant produced trans-fatty acids by most people. 
Conjugated linoleic acid (CLA) has many isomers. The main isomers, trans-10, 
cis-12 CLA and cis-9,trans-11 CLA, are commonly found in ruminant animal fat, dairy 
products, and partially hydrogenated vegetable oils (107). When given encapsulated 
individual CLA isomers, an increase in plasma triglycerides, total cholesterol, and LDL 
cholesterol was seen with trans-10, cis-12 CLA, but not with cis-9,trans-11 CLA 
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supplementation (108). The trans-10, cis-12 and CLA cis-9,trans-11 CLA isomers were 
studied in vitro at high concentrations. Both CLA treatments resulted in lower 
concentrations of esterified cholesterol and stimulated HDL-dependent cholesterol efflux 
in mouse macrophage-derived foam cells (109). 
 
Dietary Cholesterol 
 As reviewed by Grundy and Denke (110), the relationship between dietary 
cholesterol and serum circulating cholesterol levels was first observed when cholesterol 
was fed to rabbits and other species. From these studies it was assumed dietary 
cholesterol increased serum cholesterol and thus led to an increased risk for CVD. 
However, humans respond less to dietary cholesterol than most species (110, 111). The 
direct influence of dietary cholesterol and serum cholesterol levels is interrupted by the 
intense regulation of cholesterol biosynthesis by the liver. Cholesterol synthesis is 
regulated, in part, by a negative feedback mechanism. When dietary cholesterol is high, 
biosynthesis is down regulated (112). Dietary cholesterol reduces endogonous cholesterol 
synthesis by suppressing 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA 
reductase) and up-regulates acyl CoA:cholesterol acyltransferase (ACAT) activity. 
ACAT is responsible for esterifying a free fatty acid, likely unsaturated, to free 
cholesterol making cholesterol ester. When ACAT activity is increased, the free 
cholesterol pool is decreased, and LDL receptor activity, and thus LDL catabolism is 
increased. Oleic acid, the primary fatty acid substrate for ACAT, (along with arachidonic 
acid and eicosapentanoic acid) stimulates ACAT activity (113, 114). 
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Exercise and Lipid and Lipoprotein Metabolism 
 Inactivity is a major risk factor for CVD due, in part, to its effects on individual 
lipid and lipoprotein profiles. The American College of Sports Medicine and the 
American Heart Association now recommend that older adults participate in moderate 
aerobic exercise for an accumulation of 30 min/d, with each bout lasting a minimum of 
10 min at least 5 d/wk, or vigorous activity for 20 min/d for at least 3 d/wk. Moderate 
muscle strengthening activities should be done for 30 min at least 2 d/wk or vigorous 
muscle strengthening activity for 20 min/d at least 2 d/wk (115). High levels of exercise 
are associated with reduced prevalence of hypertension, elevated cholesterol, and 
diabetes mellitus. Even with low- to moderate- intensity activities (walking), women who 
expend 600-1499 kcal/wk are less likely to develop CVD with no additional reduction of 
risk seen at higher energy expenditures (116). 
 Endurance exercise may be beneficial to blood lipid profiles due to its influence 
on key lipoprotein metabolism enzymes. Such effects include increased lipoprotein lipase 
activity, decreased hepatic lipase activity (117), increased LCAT activity and reductions 
in CETP activity. By influencing these enzyme activities, changes in blood lipids are seen 
in postmenopausal women and in men including decreases in total cholesterol, LDL 
cholesterol and triglycerides with elevations in HDL cholesterol including HDL3 and 
HDL2 (62, 117). Through meta-analysis, Kelley et al. (118) reported that chronic exercise 
significantly lowered total cholesterol, LDL and triglyceride concentrations while 
increasing HDL cholesterol concentrations in women (118) and men (119). Greater 
reductions in total cholesterol were associated with reductions in body fat percentage 
(118, 119). HDL cholesterol was increased in White and African American males and 
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females, while triglycerides were decreased only in White male and females after 3 y of 
increased regular exercise (61).   
 An acute bout of exercise can be used to isolate the acute effects of exercise on 
blood lipids. These effects may mirror that of endurance exercise training such as acute 
reductions in triglycerides, increases in HDL cholesterol, and improved glucose control 
(120, 121). After an acute bout of exercise in which moderately trained females expended 
800 kcal at 75% VO2peak, an increase in total HDL cholesterol was seen at 48 h after 
exercise and an increase in HDL3 was seen immediately after exercise, but returned to 
baseline 24 and 48 h after the exercise bout (122). As long as caloric expenditure is held 
constant, the changes in serum lipids after an acute bout of exercise are not influenced by 
intensity (121). 
 
Present Study 
The objectives of this study were: 
1. To establish the relationship between the monounsaturated:saturated 
fatty acid (MUFA:SFA) ratio in beef and plasma lipoprotein 
cholesterol and inflammatory markers of CVD in 
normocholesterolemic men and postmenopausal women.  
2. To establish the relationship between the MUFA:SFA ratio of ground 
beef and the metabolic and inflammatory responses to a single bout of 
aerobic exercise in postmenopausal women. 
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Our primary hypothesis was differing fatty acid profiles in ground beef would 
differentially affect CVD risk with the high-MUFA ground beef having a more beneficial 
impact on CVD risk than low-MUFA ground beef in normocholesterolemic men and 
postmenopausal women. Also, exercise would have a beneficial additive effect on CVD 
risk factors when performed during ground beef patty consumption. 
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CHAPTER II  
GROUND BEEF FORMULATED FROM CORN-FED CATTLE INCREASES HDL 
CHOLESTEROL AND LDL DIAMETER AND DECREASES PLASMA INSULIN IN 
NORMOCHOLESTEROLEMIC MEN 
 
Introduction 
Researchers previously concluded that dietary saturated fatty acids (SFA) elevate 
serum cholesterol concentrations, whereas polyunsaturated fatty acids (PUFA) reduce 
serum cholesterol concentrations, and monounsaturated fatty acids (MUFA) have little or 
no effect (77, 78). While a recent WHO/FAO expert consultation generally confirmed 
these concepts (123), specific reports noted the importance of dietary context for the 
effects of SFA (124) as reductions in its intake is associated with reductions in HDL 
cholesterol (HDL-C) as well as LDL cholesterol (LDL-C) The major MUFA in beef, 
oleic acid, has been studied in more detail and found to lower LDL-C without affecting 
the HDL-C (70, 89, 125, 126). Monounsaturated fatty acids typically constitute 35 to 
45% of the total fatty acids in beef produced in the U.S. (80, 127). Some studies 
concluded that beef consumption resulted in decreased serum cholesterol in human 
subjects (128), while others conclude that it had no effect (75, 129, 130). The wide 
variation of oleic acid and trans-fatty acid content (TFA) in market beef (131, 132) may 
have been responsible for inconsistent study results. 
Carcasses from pasture-fed cattle are lower in total fat and typically attain USDA 
quality grade Select, whereas carcasses from corn-fed cattle are higher in total fat, 
typically grading to USDA quality grade Choice (133, 134). Select beef contains 3 – 4% 
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total extractable lipid while Choice beef contains 5 – 7% total extractable lipid (135). 
Additionally, because grasses contain a greater proportion of α-linolenic acid (18:3(n-3), 
ALA) than corn or other grains, beef from grass-fed beef cattle contains more ALA than 
beef from grain-fed cattle (131, 133), albeit the total amount remains very low. For 
example, a 114 g (4 oz) strip steak from corn-fed beef contains approximately 6 mg of 
ALA, whereas the same size strip steak from grass-fed cattle would contain about 25 mg 
of ALA (values calculated from 17). The current DRI for macronutrients recommends 
daily intakes of 1,100 mg and 1,600 mg ALA for adult women and men, respectively. 
Thus, a 114-g steak from grass fed cattle could provide 1.6 – 2.3% of the daily 
recommendation of ALA and about 4 g of total fat.    
At least 40% of average 67 pounds of per capita beef consumption in the U.S. is 
consumed as ground beef, and low-income households consume more ground beef per 
capita than high-income households (136). Unlike intact cuts of beef, ground beef is 
fabricated to a specific fat level, which can be as low as 3% total fat to an upper legal 
limit of 30% total fat (137). Statistics from July 2009 to July 2010 show that 31.4% of 
ground beef consumed in the US contains 22-30% fat, while the next 34.8%, contains 16-
22% fat. In contrast, ground beef containing 10% or less fat comprises about 18.8% 
ground beef consumption (138). Beef fat can be a significant component of the diet, and 
nutritional optimization of beef fat composition could have important health impacts (89). 
Previous work from our laboratories has shown that beef fat composition varies 
by depot, animal age and method of feeding, with corn feeding being an effective means 
to reduce SFA and TFA (131, 132, 139). However, these improvements came at the 
expense of ALA content. In an earlier study, hypercholesterolemic individuals showed 
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evidence of reduced CVD risk following consumption of 35% fat hamburger patties from 
corn-fed cattle. It became of interest to determine whether the intake of ground beef of a 
common total fat content (24% total fat) from pasture- and corn-fed cattle would 
differentially affect risk factors for CVD in normocholesterolemic individuals.   
 
Methods 
 Approval.  The study was conducted according to the Declaration of Helsinki 
guidelines. All procedures involving human subjects were approved by the Texas A&M 
University Institutional Review Board for use of human subjects in research (Protocol 
number 2005-0435). Written consent was obtained from all subjects. 
 Participants and study design. Healthy, non-smoking males between the ages of 
23 and 60 y were screened for eligibility. The 30 subjects selected were not on restrictive 
diets or medications. Family histories were obtained as part of a complete physical 
examination that included a treadmill exercise test with an electrocardiogram. Baseline 
blood chemistries were analyzed by a local laboratory (St. Joseph’s Hospital, Bryan, TX) 
and all blood chemistries were within normal ranges as defined by the testing laboratory. 
All participants were free-living and were instructed to maintain routine activities and 
body weight (± 2.2 kg of entry weight). Exercise and physical activities were not 
restricted, but participants were requested not to change their habitual level of physical 
activity. Twenty-seven of the initial 30 participants completed the study. Of the three 
non-completers, one had a reoccurrence of a previous illness, another relocated, and data 
from the third was omitted following three baseline samples that showed high TAG 
concentrations (> 5 mmol/L). 
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A three-period randomized, cross-over design was used. Each participant 
completed three, 5-wk diet interventions in a randomly assigned order with a 4-wk 
washout period between the test diet interventions. The men consumed 5 ground beef 
patties per week for 5 wk during each dietary intervention. The three interventions were 
low-MUFA ground beef, mid-MUFA ground beef and high-MUFA ground beef. The 
three diet interventions and two washout periods required a total of 23 wk to complete. 
To facilitate product distribution and blood sampling, participants were assigned 
to one of two groups comprised of 3 blocks of 5 men each, balanced with regard to age, 
body weight and total cholesterol concentration at the initial screening. Group 1 began 
the study 2 wk before group 2. Both groups rotated through all three test diets, but the 
pattern in which they crossed over differed between groups. Therefore, crossovers 
included all possible rotation sequences. Body weights were recorded weekly during the 
test phases, and body composition was measured by dual energy X-ray absorptiometry 
(DEXA) at the initial screening and at the completion of the study. 
 Diet  records. Diet records were obtained to establish baseline observations and 
encourage compliance to guidelines to consume one patty daily, five times each week for 
5 wk. Between each diet phase and once during each phase, participants completed a 3-d 
record. Records included one weekend day. Daily intake of major nutrients and dietary 
exchanges was analyzed by a registered dietitian using Nutrient Calc version 1.1 
(University of Minnesota, St. Paul, MN).   
Source of raw materials.  Cattle were fed pasture or grain-based diets 
specifically with aim to produce ground beef with MUFA:SFA of 0.70, 0.85 and 1.20, 
representing grass-fed, typical chubpack (regular), and intensively corn fed (premium) 
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ground beef (15, 16). Eighteen Angus steers were purchased as calves at 8 mo of age, 
transported to the Texas AgriLife Research Center in McGregor, TX, and fed Coastal 
burmudagrass hay (9.5% crude protein) free choice for 8 d. Twelve steers were fed a 
high-energy, corn-based diet containing (as-fed basis) 48% ground corn, 20% ground 
sorghum, 15% cottonseed hulls, 6.5% molasses, 6% cottonseed meal, 3% limestone, trace 
mineral salt (NaCl, 98%, Zn, 0.35%, Mn, 0.28%, Fe, 0.175%, Cu, 0.35%, and I, 0.007%), 
vitamin premix (vitamin A, 2.2 x 106 IU/kg; vitamin D, 1.1 x 106 IU/kg; and vitamin E, 
2.2 x 106 IU/kg), and a monensin premix (Elanco Animal Health, Greenfield, IN) to 
provide 25 mg of monensin/kg of feed (18). The remaining six steers grazed on Coastal 
burmudagrass pasture and were offered free choice coastal Burmudagrass hay 
supplemented with non-protein nitrogen. 
Six of the 12 corn-fed steers were fed for 117 d (to 12 mo of age), and the 
remaining 6 corn-fed steers and the 6 pasture/hay-fed steers were fed for 228 d (to 16 mo 
of age).  The 12-mo-old, corn-fed steers were processed at a commercial facility in 
McGregor, TX, whereas the 16-mo-old corn-fed and pasture/hay-fed steers were 
transported to the Texas A&M University Rosenthal Meat Science and Technology 
Research Center, College Station, for processing. At each facility, subcutaneous adipose 
tissue was sampled over the 12th thoracic rib along the dorsal midline according to 
commercial grading protocols and adipose tissue collected for immediate fatty acid 
composition determination to facilitate ground beef patty formulation.    
Carcasses from the pasture/hay-fed steers graded USDA low Select and carcasses 
from the steers fed corn for 228 d graded USDA low Choice (Table 1). Carcass data were 
not available for steers fed corn for 117 d because they were processed at a commercial 
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plant. However, based on previous studies (139), the cattle should have produced high 
Select/low Choice, yield grade 3 carcasses, values intermediate between grass-fed and 
long-fed cattle. 
 
 
 
TABLE 1 Production and carcass characteristics of Angus steers used to 
produce the test ground beef 
 Targeted ground beef MUFA:SFA ratio 
Item 0.80 1.10 1.40 
Age at slaughter, mo 20 15 20 
Average daily gain, kg/d 0.88 1.53 1.32 
Time on pasture or corn, mo 8 mo, pasture 4 mo, corn 8 mo, corn 
Carcass weight, kg 284.2 NA1 363.9 
Adjusted fat thickness, cm 1.09 NA 2.45 
Subcutaneous adipose tissue  
MUFA:SFA 
0.8 1.07 1.43 
Ribeye area, cm2 67.2 NA 73.7 
Kidney, pelvic & heart fat % 2 NA 2.67 
Marbling score3 340 NA 500 
Quality grade Select16 NA Choice08
Yield grade 3.03 NA 4.82 
1NA = not available. 
2MUFA:SFA ratio = (14:1n-5 +16:1n-7 + 18:1n-9 +18:1n-7)/(14:0 + 16:0 + 18:0). 
3300 = slight marbling, 400 = small marbling, 500 = modest marbling. 
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Subcutaneous adipose tissue overlying the 12th thoracic rib from the pasture/hay-
fed steers had a MUFA:SFA of 0.80 (low-MUFA). In the short-fed, corn-fed steers, the 
subcutaneous adipose tissue had a MUFA:SFA of 1.07 (mid-MUFA), whereas 
subcutaneous adipose tissue from corn-fed, long-fed steers had  a MUFA:SFA of 1.43 
(high-MUFA).  
Preparation of ground beef. Carcasses were fabricated at the Texas A&M 
Rosenthal Meat Science & Technology Center, Texas A&M University. Fat and lean 
trims from the plate and flank were combined at the appropriate ratios to yield 24% total 
fat. Notably, the plate and flank regions from the pasture/hay-fed cattle did not contain 
sufficient fat trim to achieve 30% total fat.   
Ground beef patties (114 g; 4 oz) were formed with an automated patty maker, 
quick-frozen to -20°C, and individually vacuum-packaged. The final MUFA:SFA of the 
low-MUFA, mid-MUFA and high-MUFA ground beef patties were 0.71, 0.83 and 1.10, 
respectively. These values were lower than predicted by the subcutaneous fatty acid 
composition because the plate and flank used to formulate the ground beef are more 
saturated than the subcutaneous fat overlying the loin (132). Each low-MUFA ground 
beef patty contained 2.5 g more SFA and 3.4 g less MUFA than the high-MUFA patties 
(Table 2). Also, each low-MUFA patty contained 37 mg more trans-vaccenic acid and 60 
mg more ALA than the high-MUFA ground beef patties.   
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TABLE 2 Fatty acid composition of low MUFA, mid MUFA, and high MUFA 
ground beef1 
  
Fatty acid Low MUFA Mid MUFA High MUFA 
  g/114-g ground beef patty 
14:0 (myristic) 0.99 0.97 0.66 
14:1 (myristoleic) 0.28 0.26 0.22 
16:0 (palmitic) 8.78 8.43 7.89 
16:1(n-7) (palmitoleic) 0.85 0.83 0.97 
18:0 (stearic) 5.57 4.98 4.31 
18:1(trans-11) (trans-vaccenic) 1.06 0.97 0.69 
18:1(n-9) (oleic) 10.07 11.06 13.25 
18:1(n-7) (cis-vaccenic) 0.29 0.36 0.46 
18:2(n-6) (linoleic) 0.55 0.49 0.56 
18:3(n-3) (α-linolenic) 0.09 0.04 0.03 
18:2(cis-9,trans-11) 0.18 0.13 0.14 
18:2(trans-20,cis-12) 0.04 0.07 0.09 
Total trans 1.28 1.17 0.92 
MUFA:SFA ratio 0.71 0.83 1.10  
1Data are means for three batches of ground beef per treatment group. 
 
 
 
On the day of the initial blood sampling, each participant received an unlabeled 
box containing all of the patties for the first 5-wk trial. A new box of patties was provided 
at the beginning of the subsequent, two intervention periods. No restrictions were placed 
on how the beef was to be prepared. Participants were instructed to consume all to the 
beef from a single patty at one meal. 
 Collection and analysis of blood samples.  Prior to the initiation of the dietary 
treatments and at the end of each diet phase, after 5 min of seated rest, blood was 
collected from the subjects into EDTA vacutainers from a vein in the antecubital fossa 
using standard phlebotomy procedures. Plasma was harvested from the blood collected 
with EDTA, and lipoproteins preserved (140). Lipoprotein separation involved density 
gradient ultracentrifugation employing human density intervals (131). The diameters of 
LDL and HDL particles isolated from plasma were determined by non-denaturing 
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gradient gel electrophoresis (141). Particle diameters were determined by comparison 
with migration distances of standard proteins of known hydrated diameter (High 
Molecular weight standards, Amersham Pharmacia, Piscataway, NJ) (142). 
Plasma total cholesterol, triacylglycerol, insulin and glucose were determined by 
separate enzymatic assays (Sigma Chemical Co., St. Louis, MO). Serum hs-CRP was 
determined using an ELISA test kit (Alpha Diagnostic International, Inc., San Antonio, 
TX).   
 Fatty acid composition of plasma and test ground beef. Plasma fatty acids and 
fatty acid composition of every batch of ground beef (n = 3 for each ground beef type) 
were measured. Total lipid was extracted and methylated (143, 144). Fatty acid methyl 
esters (FAME) were analyzed with a Varian gas chromatograph (model CP-3800 fixed 
with a CP-8200 autosampler, Varian Inc., Walnut Creek, CA) equipped with a fused 
silica capillary column CP-Sil88 [100 m x 0.25 mm (i.d.)] (Chrompack Inc., Middleburg, 
The Netherlands) (16). Helium was used as the carrier gas (1.2 mL/min). After 32 min at 
180oC, oven temperature was increased at 20oC/min to 225oC and held for 13.75 min.  
Injector and detector temperatures were at 270 and 300oC, respectively. Individual 
FAME were identified using genuine standards (Nu-Chek Prep, Inc., Elysian, MN) and 
expressed as a g/100 g total FAME analyzed or as g/114 g ground beef patty. 
 Statistical analysis. Nutrient and dietary exchange data were analyzed by 
analysis of variance (SuperAnova, Abacus Concepts, Inc., Berkeley, CA). Intakes during 
each test phase were compared to the pooled values for two habitual periods. Final (after 
test, pooled across treatment; n = 81) plasma glucose, lipids, insulin, hs-CRP, lipoprotein 
particle sizes and fatty acids were compared to pooled initial values (n = 81) by analysis 
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of variance. Also, changes from corresponding initial values for each variable were 
calculated and compared statistically to no change by analysis of variance. Because each 
participant randomly rotated through all three diets, values reported for changes from 
baseline are means ± standard error of the mean (SE) for n = 27 observations. 
 
Results 
Nutrient and dietary exchange intake. Dietary records indicated no significant 
differences in energy intake or intakes of protein, carbohydrate, cholesterol, linoleic acid 
(18:2(n-6)) or ALA (Table 3).  
Saturated fat intake was greatest when participants consumed low-MUFA ground 
beef, while MUFA and oleic acid intake was greatest when participants consumed the 
high-MUFA ground beef. Consumption of the mid-MUFA ground beef caused no 
significant change in the intakes of any major fatty acid.  Differences in total TFA intake 
could not be evaluated due to inadequate food database documentation. However trans-
fatty acids from beef were greatest while consuming the low-MUFA beef, 1.28 g/d, and 
lowest while consuming the high-MUFA ground beef, 0.92 g/d. When diets were 
characterized as dietary exchanges, only the intake of high-fat meat changed between the 
habitual and test diets (from 0.5 to approximately 1.5 exchanges/d; Table 4). The increase 
in intake of high-fat meat was offset sufficiently by reduced intake of medium-fat meat so 
that there was not a significant difference in total meat intake. 
 
 TABLE 3 Daily intake of major nutrients for habitual diets and for test diets of men rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA), medium in monounsaturated fatty acids (Mid 
MUFA), or high in monounsaturated fatty acids (High MUFA)1
  
  Treatment group  
Item Habitual Low MUFA Mid MUFA High MUFA P-values  
Total energy, kjoule/d 8,632 ± 501 9,337 ± 909 8,968 ± 1,049 9,065 ± 535 0.20 
Protein, g/d 97 ± 5 97 ± 10 92 ± 10 91 ± 8 0.32 
Carbohydrate, g/d 211 ± 13 224 ± 26 225 ± 27 222 ± 15 0.23 
Cholesterol, mg/d 353 ± 45 325 ± 44 347 ± 59 325 ± 44 0.37 
Saturated fat, g/d 30 ± 2b 39 ± 4a 36 ± 4ab 36 ± 2ab <0.01 
Monounsaturated fat, g/d 26 ± 2b 31 ± 4ab 27 ± 3ab 32 ± 3a 0.05 
Polyunsaturated fat, g/d 10 ± 1 11 ± 1 9 ± 2 12 ± 2 0.15 
Oleic acid, 18:1(n-9), g/d 22.4 ± 2.0b 27.0 ± 3.3ab 23.8 ± 2.9ab 27.4 ± 2.2a 0.04
Linoleic acid, 18:2(n-6), g/d 8.4 ± 0.8 7.6 ± 1.0 6.7 ± 1.3 9.0 ± 1.5 0.35 
α-Linolenic acid, 18:3(n-3), g/d 1.1 ± 0.2 1.0 ± 0.3 1.0 ± 0.3 1.0 ± 0.2 0.36  
1Data were derived from 3-d diet records collected during each test period, to include one weekend day.  Data for the habitual 
diets were pooled over the two washout periods.  abMeans without common superscripts differ (P < 0.05). 
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 TABLE 4 Dietary exchanges for habitual diets and for test diets of men rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), medium in monounsaturated fatty acids (Mid MUFA), or 
high in monounsaturated fatty acids (High MUFA)1 
  
  Treatment group  
Item Habitual Low MUFA Mid MUFA High MUFA P-values  
Bread/starch 8.1 ± 0.5 9.1 ± 1.2 9.2 ± 1.3 8.6 ± 0.5 0.18 
Fat 6.7 ± 0.9 7.0 ± 1.6 7.0 ± 1.8 7.7 ± 1.1 0.26 
Fruit 0.9 ± 0.2 1.0 ± 0.3 1.3 ± 0.3 0.7 ± 0.2 0.24 
Meat, high-fat 0.5 ± 0.1b 1.7 ± 0.4a 1.4 ± 0.4a 1.4 ± 0.4a <0.01 
Meat, medium-fat 6.2 ± 0.5 6.0 ± 0.9 5.7 ± 0.7 5.5 ± 0.4 0.30 
Meat, low-fat and lean 2.3 ± 0.4 2.6 ± 0.6 2.2 ± 0.6 2.6 ± 0.6 0.44 
Meat, total 8.9 ± 0.8 10.6 ± 1.3 10.4 ± 1.8 9.9 ± 1.2 0.19 
Milk, whole, low-fat and skim 0.5 ± 0.1 0.3 ± 0.1 0.4 ± 0.3 0.7 ± 0.2 0.25 
Other carbohydrates 3.3 ± 0.4 3.4 ± 0.6 2.7 ± 0.6 3.4 ± 0.7 0.28 
Vegetables 1.3 ± 0.2 1.4 ± 0.4 1.6 ± 0.4 1.1 ± 0.3 0.41 
  
1Data were derived from 3-d diet records collected at each interval.  Data for the habitual diets were pooled over the two 
washout periods.  
abMeans without common superscripts differ (P < 0.05). 
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TABLE 5 Initial and final characteristics of men rotated through ground beef 
types low in monounsaturated fatty acids, medium in 
monounsaturated fatty acids, or high in monounsaturated fatty acids 
(pooled across dietary interventions)1 
  
Item Baseline Intervention P-values  
Age, y 35.8 ± 1.3 --- --- 
Body weight, kg 85.6 ± 2.7 86.2 ± 2.7 0.15 
Body mass index, kg/m2 27.1 ± 0.8 27.3 ± 0.8 0.17 
Android fat, % total fat 35.3 ± 2.4 35.6 ± 2.4 0.69 
Gynoid fat, % total fat 32.7 ± 2.5 31.1 ± 1.8 0.29 
Total body fat, % 27.4 ± 2.0 26.9 ± 1.8 0.31 
Lipid values 
Glucose, mmol/L 5.10 ± 0.04 5.03 ± 0.04 0.14 
Triacylglycerol, mmol/L 1.28 ± 0.06 1.21 ± 0.11 0.09 
Total cholesterol, mmol/L 4.73 ± 0.10 4.72 ± 0.09 0.97 
LDL cholesterol, mmol/L 3.02 ± 0.09 3.00 ± 0.09 0.55 
HDL cholesterol, mmol/L 1.17 ± 0.02 1.22 ± 0.04 <0.01 
LDL:HDL 2.68 ± 0.10 2.57 ± 0.18 0.04 
Insulin, mU/L 5.96 ± 0.53 4.52 ± 0.42 <0.01 
hs-CRP, mg/L 1.97 ± 0.44 1.82 ± 0.29 0.70 
LDL particle diameter, nm 26.05 ± 0.13 26.38 ± 0.12 0.05 
HDL2 particle diameter, nm 11.45 ± 0.08 11.25 ± 0.08 0.04 
HDL3 particle diameter, nm 9.29 ± 0.03 9.12 ± 0.04 <0.001 
  
1Data are means ± SE for 27 values for age and morphometric measurements and 81 
values for lipid measurements, pooled across 27 men and three ground beef 
interventions.  
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Main effects of ground beef interventions. Final lipid and lipoprotein 
parameters did not differ among the ground beef interventions and so the effects of 
ground beef consumption per se were assessed using pooled data comparisons between 
baseline (n = 81) and intervention values (n = 81).  Body weight, BMI, android fat, 
gynoid fat and total body fat were unchanged over the 23-wk duration of the study 
(Table 5).  
Ground beef interventions decreased plasma TAG (P = 0.09), and increased 
HDL-C (P < 0.01) and the plasma LDL:HDL (P = 0.04). Plasma insulin was uniformly 
decreased by the ground beef interventions (P < 0.01) and aggregate hs-CRP was 
unaffected. The ground beef interventions increased LDL particle diameter (P = 0.05), 
but decreased HDL2 and HDL3 particle diameters (P = 0.04 and P < 0.001, respectively). 
There was a small decrease in plasma palmitoleic acid and a similarly small 
increase in plasma stearic acid (both P = 0.07) that resulted in a significant (P = 0.04) 
decrease in the palmitoleic:stearic (from 0.185 to 0.156; Table 6). Plasma trans-vaccenic 
and ALA both were depressed after the ground beef interventions (P = 0.02). 
Conversely, consumption of the ground beef patties increased plasma arachidonic acid 
(P < 0.001). The total plasma fatty acid concentration did not change with the ground 
beef interventions (414 vs 363 µmol/L, respectively; baseline vs intervention P = 0.25). 
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TABLE 6 Initial and final plasma fatty acids of men rotated through ground 
beef types low in monounsaturated fatty acids, medium in 
monounsaturated fatty acids, or high in monounsaturated fatty acids 
(pooled across dietary interventions)1 
  
Fatty acid Baseline Intervention P-values  
µmol/100 µmol total fatty acids2 
Palmitic, 16:0 23.89 ± 0.29 23.31 ± 0.31 0.36 
Palmitoleic, 16:1(n-7) 1.54 ± 0.09 1.34 ± 0.08 0.07 
trans-Vaccenic, 18:1(trans-11) 0.40 ± 0.07 0.17 ± 0.05 0.02 
Stearic, 18:0 8.43 ± 0.12 8.81 ± 0.13 0.07 
Oleic, 18:1(n-9) 21.06 ± 0.34 20.85 ± 0.36 0.89 
Linoleic, 18:2(n-6) 32.99 ± 0.59 32.85 ± 0.58 0.54 
α-Linolenic, 18:3(n-3) 0.33 ± 0.05 0.20 ± 0.04 0.02 
Arachidonic, 20:4(n-6) 6.54 ± 0.26 7.92 ± 0.20 <0.001 
Eicosapentaenoic, 20:5(n-3) 0.31 ± 0.05 0.34 ± 0.05 0.86 
Docosahexaenoic, 22:6(n-3) 0.76 ± 0.11 0.83 ± 0.11 0.31 
Palmitoleic:stearic acid ratio 0.185 ± 0.012 0.156 ± 0.010 0.04 
  
1Data are means ± SE for 81 values, pooled across 27 men and three ground beef 
interventions. 
2Total plasma fatty acid concentrations were 414 µmol/L (baseline) and 363 µmol/L 
(intervention); concentrations were not different, P = 0.25. 
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FIGURE 1 Absolute changes from baseline (mmol/L) for triacylglycerol (TAG), 
LDL-C and HDL-C in men rotated through test group beefs low in 
monounsaturated fatty acids (Low MUFA), medium in monounsaturated fatty 
acids (Mid MUFA), or high in monounsaturated fatty acids (High MUFA).  Values 
are expressed as mean ± SEM, n = 27.  Different from zero change at ***P < 0.001. 
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Changes from baseline for each ground beef intervention. Although the low-, 
mid- and high-MUFA ground beef caused uniform decreases from baseline in plasma 
TAG (0.04 to 0.10 mmol/L decreases), the change from baseline TAG were not 
significant (P > 0.10). Similarly, there was no overall effect of the dietary interventions 
on LDL-C (Figure 1). Only the high-MUFA ground beef intervention significantly 
increased HDL-C from baseline values (P < 0.001).   
The low-MUFA ground beef had no effect on LDL particle diameter, whereas 
the mid- and high-MUFA ground beef interventions increased LDL particle diameter 
from baseline values (0.45 to 0.55 nm increases; P < 0.05) (Figure 2). Although the 
ground beef interventions caused an overall decrease in HDL2 diameter (Table 5), the 
changes from baseline for the separate ground beef interventions were not significant (P 
> 0.10). The mid-MUFA ground beef caused the greatest decrease in diameter for HDL3, 
but all ground beef interventions significantly reduced HDL3 diameter. 
The mid-MUFA ground beef intervention significantly reduced plasma glucose 
from baseline (P < 0.05) and the high-MUFA ground beef caused a significant 
depression from baseline for plasma insulin (P < 0.01; Figure 3). The low- and mid-
MUFA ground beef interventions decreased plasma ALA from baseline (P < 0.05). 
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FIGURE 2 Absolute changes from baseline (nm) for LDL, HDL2 and HDL3 
particle diameter in men rotated through test group beefs low in monounsaturated 
fatty acids (Low MUFA), medium in monounsaturated fatty acids (Mid MUFA), or 
high in monounsaturated fatty acids (High MUFA).  Values are expressed as mean 
± SEM, n = 27.  Different from zero change at *P < 0.05, **P < 0.01, ***P < 0.001. 
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FIGURE 3 Magnitude changes from baseline for glucose (mmol/L), 
insulin(mU/L) and hs-CRP (mg/L) in men rotated through test group beefs low in 
monounsaturated fatty acids (Low MUFA), medium in monounsaturated fatty 
acids (Mid MUFA), or high in monounsaturated fatty acids (High MUFA).  Values 
are expressed as mean ± SEM, n = 27.  Different from zero change at *P < 0.05, **P 
<.01. 
 
 
 
 43
Discussion 
Nutrient and dietary exchange intake.  Total energy intake and intakes of 
protein, carbohydrates, and fat were essentially identical to values reported in two 
previous studies from our laboratory on the effects of beef on plasma lipoprotein 
concentrations (130, 131). Although nutrient intake was not strictly controlled, it was 
carefully monitored. Very few food restrictions were placed on the participants either 
during the test periods or during the intervening washout periods. We purposely did not 
strictly control dietary intake of nutrients by participants, but stipulated only that the 
ground beef patties replaced an equal portion of meat (beef or otherwise) that they 
normally would have consumed. Dietary records indicated that the participants generally 
consumed the ground beef patties intact, and usually included them in their noontime 
meals. This encouraged compliance and allowed us to evaluate the effects of the test 
ground beef patties in a more likely, i.e., free-living setting.   
By design, the high-MUFA ground beef contained nearly 4 g more MUFA per 
patty than did the low-MUFA ground beef, and the mid-MUFA ground beef was 
intermediate. Thus, each participant on the high-MUFA diet consumed nearly 20 g more 
MUFA per week than those consuming the low-MUFA ground beef. The mid-MUFA 
ground beef intervention was included as it most closely resembled regular chub pack 
ground beef in total fat and fatty acid composition (131, 132). 
Ground beef comprises a large proportion of the beef consumed in the U.S. 
(145).  Also, the ground beef used in this study was representative of the range of ground 
beef that is readily available to consumers (131, 132), and the amounts of beef consumed 
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in the study would result in an annual consumption of 65 pounds per year, near to the 
national average in the US. The MUFA:SFA of the ground beef from pasture-fed cattle 
(low-MUFA; 0.71) was similar to the MUFA:SFA for a specialty branded ground beef 
product (0.73) (131). Low MUFA:SFA products typically are produced from cattle that 
are fed little or no grain, or which are processed at a young age (139). The high-MUFA 
ground beef (1.10) was similar to that for a branded Angus product (1.12) (130, 131). 
We demonstrated previously that MUFA in beef, and especially oleic acid, increase with 
the amount of time that cattle are fed a grain-based diet (139). 
The most profound differences in documented fat intake were for saturated and 
total fat. Individuals in the low-MUFA ground beef group consumed nearly 10 g/d more 
saturated fat and 15 g/d more total fat than in their habitual diets. This reflected the 
primary contribution of animal products to saturated and total fat intake. In spite of this, 
none of the test ground beef patties increased LDL-C, possibly because most of the 
increase in saturated fat was in the form of stearic acid (146). 
 Plasma TAG, insulin and glucose. We previously demonstrated that low-
MUFA ground beef increased, and high-MUFA ground beef decreased plasma TAG 
(131). In the current study, the ground beef interventions caused an overall depression in 
plasma TAG and plasma palmitoleic acid and an increase in plasma stearic acid. There 
was a highly significant correlation between plasma palmitoleic acid and TAG (r = 0.38, 
P < 0.0001), consistent with previous studies (131, 147). Notably, in both this and the 
previous study (131) the high-MUFA patties increased plasma stearic acid with 
approximately a 20% decrease in palmitoleic:stearic acid ratio, suggesting that high-
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MUFA ground beef may depress hepatic stearoyl-CoA desaturase-1 (SCD1) activity. 
Hepatic SCD1 activity supports TAG synthesis (148), and SCD1 gene expression and 
activity are activated by dietary stearic acid and depressed by oleic acid in mice (149). 
This argues strongly that SCD1 activity in part at least regulates plasma TAG in humans. 
Similar evidence for plasma palmitoleic as a predictor of cardiovascular mortality was 
provided by Warensjo et al. (150). The reduction in plasma insulin and the small 
reductions in TAG and glucose are consistent with this interpretation and effects seen in 
men consuming additional amounts of dairy fat (151), albeit specific mechanisms 
underlying the effect may differ. 
 Plasma lipoprotein cholesterol fractions. We recently reported the effects of 
two high-fat, hamburger preparations on cholesterol metabolism in a group of mildly 
hypercholesterolemic men (131). By definition, ground beef contains a maximum of 
30% total fat (137). In that study, 10 men were first fed 35% fat hamburger high in SFA 
and TFA (MUFA:SFA = 0.95, TFA = 1.72 g/patty), and then were rotated to 35% 
hamburger high in MUFA and lower in TFA (MUFA:SFA = 1.31, TFA = 1.28 g/patty). 
The high-SFA hamburger markedly reduced HDL-C and LDL particle diameters while 
increasing plasma TAG; these values returned to baseline values after the high-MUFA 
hamburger intervention (131). Notably, while the 35% fat low-MUFA:SFA hamburger 
intervention in the earlier study actually contained more oleic acid per patty (15 g) than 
the 24% fat high-MUFA ground beef of the current study (13.2 g) it also provided 9.6 g 
more palmitic and 0.8 g more TFA per patty. This suggests that, in our ground beef 
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intervention studies, the SFA and TFA content may have been more important in 
altering risk factors for CVD than the oleic acid content. 
None of the ground beef interventions of the current study reduced LDL particle 
diameters, and in fact the mid- and high-MUFA ground beef interventions increased 
LDL diameters. Thus, we were unable to reproduce the depression in LDL particle 
diameters caused by 35% fat hamburger from grass-fed cattle in our previous study 
(131). Similarly, serum hs-CRP was not affected by beef consumption. To our 
knowledge, the current and previous studies (131) are the only investigations in which 
the effects of supplemental beef on lipoprotein particle diameters or markers of vascular 
inflammation have been reported.   
The current study also demonstrated a very clear reduction in HDL3 particle 
diameters with all beef interventions that was independent of ground beef fatty acid 
composition. We know of no other study that has reported a reduction in the diameters 
of the individual HDL subclasses. Arsenault et al. (152) reported that HDL-C levels are 
the best correlates of HDL particle diameter in men (r = 0.58) and women (r = 0.62). 
Men and women with small HDL particles plus low HDL concentrations were at 
increased risk for CVD, as assessed by their cardiometabolomic risk profile (152). We 
observed a significant, positive correlation between HDL particle diameter and HDL-C 
(r = 0.26, P = 0.01) in the current study, but we also demonstrated increased HDL-C and 
reduced HDL diameter after the high-MUFA ground beef intervention. The relationship 
between HDL-C and particle diameter was true only for HDL2, as there was no 
correlation between HDL-C and HDL3 particle diameter (r = 0.06, P = 0.44). Because 
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depressed HDL particle diameter was accompanied by elevated HDL-C in this study, we 
cannot ascertain if this represents increased or decreased risk for CVD.   
Plasma and beef ALA. Mente et al. (89) conducted a systematic search for 
prospective cohort studies or randomized trials investigating dietary exposures in 
relation to CVD. They found strong evidence to support valid associations of protective 
factors for (among others) dietary MUFA, but insufficient evidence for total fat, SFA, 
PUFA or ALA. The low-MUFA ground beef of this study had three times the ALA of 
the high-MUFA ground beef, i.e., 90 vs 30 mg per ground beef patty, but this had no 
significant impact on the daily ALA intake. Our data indicated an overall lower plasma 
ALA after consumption of the low- and mid-MUFA ground beef preparations, and 
neither eicosopentaenoic (20:5(n-3)) nor docosahexaenoic acid (22:6(n-3)) 
concentrations were affected by the ground beef interventions. These data argue strongly 
that 24% fat ground beef from pasture-fed cattle does not provide enough ALA to have 
any impact on the metabolism of n-3 fatty acids. Interestingly, the 35% fat, low-MUFA 
hamburger used in our earlier study provided 63 mg ALA per patty, indicating that the 
low-MUFA ground beef in the present study was comparatively rich in ALA.  
Greater enrichment of beef with ALA can be achieved by allowing cattle to graze 
on pasture for much longer periods of time (up to 30 mo of age) (133), or by feeding 
flaxseed to cattle (153). However, the concentration of ALA in beef from these cattle 
would be at most 200 mg per 114-g beef serving (calculated from reported percentages 
of ALA) (133, 152). This is much less than the amount of ALA provided to human 
subjects in the form of flaxseed, margarine, or walnut oil (1 – 2 g/d) (154-156). Thus, 
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although supplementary ALA can lower plasma TAG (155) and hs-CRP (156), this 
cannot occur at the concentrations of ALA in beef from grass-fed cattle. Instead, the 
elevation of SFA and TFA that has been demonstrated consistently in beef from pasture-
fed animals (131, 133, 139) apparently overwhelms any potentially beneficial effects of 
the greater amounts of ALA. 
General considerations. There is convincing evidence that high-MUFA diets 
lower plasma cholesterol and TAG, usually by decreasing LDL-C (70, 126). 
Furthermore, studies that have included elevated beef intake have not demonstrated an 
increase in LDL-C (75, 129-131). However, it was not the intent of this study to 
recommend daily consumption of ground beef. It also is recognized that ground beef 
produced from carcasses of pasture-fed cattle typically is much leaner than the test 
ground beef patties developed for this study. However, none of the test ground beef 
patties had negative effects on risk factors for CVD, including the mid-MUFA ground 
beef, which was formulated to be similar to regular chub-pack ground beef. The high-
MUFA ground beef actually reduced risk factors for CVD by increasing HDL-C and 
LDL particle diameter as well as decreasing plasma insulin. Thus, this study provided no 
evidence that beef from pasture-fed cattle is nutritionally superior to beef from typical 
commercially produced (corn-fed) cattle in products where total fat content is similar.  
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CHAPTER III 
HIGH-OLEIC GROUND BEEF AND RISK FACTORS FOR CARDIOVASCULAR 
DISEASE IN POSTMENOPAUSAL WOMEN 
 
Introduction 
With cardiovascular disease (CVD) affecting the lives of over 26 million 
Americans, and being the leading cause of preventable death in the United States, the 
American Heart Association (AHA) has strived to provide “heart healthy” 
recommendations. The previous recommendation of the AHA was to consume a low-fat 
diet, especially low in saturated fatty acids (SFA). At that time, the AHA recommended 
that fat calories be replaced by carbohydrate. Unknowingly, consumers might have 
increased their risk of heart disease by increasing plasma triglycerides, Lp(a), and 
decreasing HDL cholesterol and LDL particle size (67-69). These findings resulted in 
the evaluation of fatty acids and their effect on CVD (73). While the recommendation 
for a reduction in saturated fat still remained, the AHA recognized diets that provided up 
to 40% of dietary energy in the form of unsaturated fat were as heart-healthy as low-fat 
diets (70, 71). An outcome of this official opinion has been the reevaluation of the 
nutritional properties of a number of higher fat foods such as dairy, nuts, and dietary oils 
such as olive oil rich in the monounsaturated fatty acid (MUFA), oleic acid (18:1n-9) 
(71). Although red meat is high in MUFA, especially oleic acid, it is still recommended 
to abstain from red meat consumption to maintain good heart health. The primary 
objective of this study was to establish the relationship between the MUFA:SFA ratio in 
 
 50
beef and plasma lipoprotein cholesterol and inflammatory markers of CVD in 
postmenopausal women. 
 
Methods 
 Subjects. The study protocol was reviewed and approved by Texas A&M 
University Institutional Review Board for the use of human subjects in research (2008-
125) and all participants gave written consent. Twenty-nine postmenopausal women 
were recruited from the local Bryan/College Station, Texas community. Nineteen 
women completed the study. The subjects were women whose last menstrual period was 
over 1 y prior to enrollment of the study by natural or surgical means with or without 
ovaries. Subjects were able to walk briskly for 20 min without chest pain or fatigue, 
were non-smokers with no history of CVD, stroke or diabetes, had normal liver function 
tests, normal fasting glucose, normal resting electrocardiogram, and serum total 
cholesterol of less than 6.72 mmol/L, and must not be taking lipid lowering drugs. 
Baseline characteristics of the participants are found in Table 7. 
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TABLE 7 Baseline characteristics for subjects1 
  
Item Mean SE  
Age, y 57.8 1.7  
Body weight, kg 70.7 4.0  
Body mass index, kg/m2 26.4 1.4  
Android fat, % total fat 45.6 2.6  
Gynoid fat, % total fat 49.6 1.5 
Total body fat, % 42.2 1.9  
1Data are means ± SE for 19 women. 
  
 
 
Study design. This experiment tested the hypothesis that risk factors for CVD 
would be lower in postmenopausal women after consumption of ground beef naturally 
enriched with MUFA than after consumption of ground beef enriched with SFA. The 19 
women were allotted to groups for a crossover design. The first group was fed high-SFA 
ground beef for a 6 wk period, and following a 4 wk habitual diet washout period, was 
rotated to a high-MUFA ground beef. The second group was fed a high-MUFA test 
ground beef for a 6 wk period, and following a 4 wk habitual diet washout period, was 
rotated to a high-SFA test ground beef. 
The beef was supplied to the participants in the form of 114 g, raw ground beef 
patties. The frozen, vacuum-packaged ground beef patties for an entire diet period were 
delivered to the participants on or before the first day of the diet period. The participants 
were asked to replace one of their normal meat servings with a patty 5 d/wk. No 
restrictions were placed on how the patty was to be prepared other than the patty should 
be cooked to an internal temperature of 71˚C, one patty should be prepared at a time, and 
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all of the patty should be consumed in one sitting. The subjects were not informed as to 
which test patty they had been assigned.  
Baseline testing. At study entrance, each subject underwent: a complete history, 
physical exam by a physician, height and body weight measurements, and a DEXA scan.  
Test patties. The low-MUFA ground beef patties were made from chub pack 
ground beef, purchased from a local retail outlet with a MUFA:SFA ratio of 0.9. The 
high-MUFA patties were made from Akaushi ground beef (Heartbrand Beef, Yoakum, 
TX) with a MUFA:SFA ratio of 1.3 (Table 8). Patties were individually vacuum-packed, 
quick-frozen and boxed by diet type. Patties were formulated to contain 20% fat, but 
after cooking, the low-MUFA patties contained 19.4 g/100g and the high-MUFA patties 
contained 22.5/100g 
 
 
TABLE 8 Fatty acid composition of low MUFA and high MUFA ground beef 
patties1 
  
Fatty acid Low MUFA High MUFA 
g/100-g cooked ground beef patty 
Total lipid   19.4  22.5 
14:0 (myristic) 0.60 0.59  
14:1 (myristoleic) 0.09 0.35  
16:0 (palmitic) 4.88 5.30  
16:1 (n-7) (palmitoleic) 0.56 0.98  
18:0 (stearic) 3.41 2.73  
18:1 (trans-11) (trans-vaccenic) 0.78 0.66 
18:1 (n-7) (cis-vaccenic) 0.29 0.49 
18:1 (n-9) (oleic) 7.34 10.24  
18:2 (n-6) (linoleic) 0.36 0.44  
MUFA:SFA ratio 0.9 1.3  
1Data are means for three batches of ground beef per treatment group. 
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Collection and handling of blood samples. Blood was collected from an arm 
vein prior to initiation of the dietary treatments, at the end of each diet phase 24 h before 
and after exercise. Plasma was harvested from the blood collected with 15% EDTA. 
Serum was harvested from the blood with clot separation. All serum and plasma samples 
were stored at -80°C. 
Fatty acid composition of plasma and test ground beef. Fatty acids were 
measured in the baseline plasma, plasma taken after 6 wk of each test beef treatment, 24 
h before and 24 h after exercise. Additionally, fatty acid composition, along with total fat 
and moisture of the dietary ground beef patties were measured. Total lipid was extracted 
and methylated as described (143, 144). Fatty acid methyl esters were analyzed with a 
Varian gas chromatograph (model CP-3800 fixed with a CP-8200 autosampler, Variam 
Inc., Walnut Creek, CA). Separation of fatty acid methyl esters was accomplished on a 
fused silica capillary column CP-Sil88 [100m x 0.25mm (i.d.)] (Chrompack Inc., 
Middleburg, The Netherlands) with helium as the carrier gas (1.2 mL/min). Oven 
temperatures began at 150°C and were increased to 160°C at a rate of 1°C/min. The 
oven temperature rose further to 167°C at a rate of 0.2°C/min. The temperature 
increased a rate of 1.5°C/min to a final temperature of 225°C where it was held for 26 
mins. Injector and detector temperatures were at 270°C. Individual fatty acid methyl 
esters were identified using genuine standards (Nu-check Prep, Inc., Elysian, MN and 
Sigma-Alderich Co.) and expressed as a g/100 g total fatty acid methyl esters analyzed 
or as g/100 g hamburger patty. 
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Fat and moisture of the dietary ground beef patties were measured by CEM 
Corp’s SMART Trac Moisture and Fat Analysis system (157). 
Lipoprotein analysis. Serum aliquots kept at -80°C were sent to SpectraCell 
Laboratories, Inc. (Houston, TX) for complete lipoprotein density and particle number 
analyses. A complete “Lipoprotein Particle Profile™” test was provided using the 
lipoprotein subgroup particle number analysis method. Lipoprotein particles were 
stained with a fluorescent dye and separated utilizing a patented continuous gradient 
over a range of d = 1.00 – 1.30 g/cm3 generated by analytical ultracentrifugation. Once 
separated, the fluorescence of the lipoprotein particles was measured in a high 
performance liquid chromatography type flow system. For processing the fluorescence 
response was normalized to a cholesterol scale with a proprietary algorithm. Values 
corresponding to each lipoprotein subgroup at their specific densities were determined 
using a multiple Gaussian fit/integration routine (158). 
Diet records. Prior to each diet phase, and once during each phase, participants 
completed a 4-d record (to include one weekend day). The diet records were analyzed 
for nutrient composition to establish baseline observations, and encourage compliance 
with total patty consumption requirement. The records were analyzed using Nutritionist 
Pro (Axxya Systems, Stafford, TX). 
Statistical analysis. Data were analyzed as a paired t-test, comparing baseline 
(habitual) values to values after 6 wk on the test diet.  Thus, each participant served as 
her own control.  Because each participant randomly rotated through all three diets, 
reported values are means ± standard error of the mean (SE) for n = 19 observations. 
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Results 
Dietary records indicated that when on a test diet, participants consumed a 
greater amount of total MUFA and oleic acid in patterns consistent with their test ground 
beef interventions. There were no significant differences in cholesterol, protein, or 
carbohydrate intake (Table 9).   
 
 
TABLE  9 Total daily energy intake per day from major nutrients for habitual diets 
(Baseline) and for test diets of women rotated through test ground beefs low 
in monounsaturated fatty acids (Low MUFA) or high in monounsaturated 
fatty acids (High MUFA)1 
Nutrient Baseline Low MUFA High MUFA 
Total energy, kcal 1,662 ± 131 1,601 ± 98 1,688 ± 113 
Protein, g 67.8 ± 4.9 74.0 ± 5 74.2 ± 5.2 
Carbohydrate, g 189 ± 16 177 ± 15 188 ± 14 
Fat, g 62.2 ± 6.8 65.3 ± 3.8 69.1 ± 4.7 
Saturated fat, g 20.0 ± 2.3 23.6 ± 1.7 24.2 ± 1.8 
Monounsaturated fat, g 15.1 ± 1.9 19.3 ± 1.1a 21.6 ± 1.5a 
Polyunsaturated fat, g 8.1 ± 0.8 6.4 ± 0.5 8.0 ± 1.0 
Trans-unsaturated fat, g 0.8 ± 0.2 1.0 ± 0.3 1.1 ± 0.2 
Cholesterol, mg 202 ± 21 274 ± 40 241 ± 28 
Oleic acid, g 12.8 ± 1.7 16.5 ± 1.0a 18.6 ± 1.4a 
Linoleic acid, g 6.1 ± 0.7 4.8 ± 0.5 6.1 ± 0.8 
Linolenic acid, g 0.7 ± 0.1 0.4 ± 0.1a 0.6 ± 0.1 
Eicosapentaenoic acid, g 0.04 ± 0.02 0.06 ± 0.04 0.06 ± 0.04 
Docosahexaenoic acid, g 0.05 ± 0.02 0.12 ± 0.07 0.12 ± 0.07 
Fiber, g 18.3 ± 2.6 18.1 ± 2.4 16.9 ± 1.5 
Sugar, g 68.3 ± 5.9 70.8 ± 8.6 81 ± 10.6 
Sodium, mg 2,903 ± 205 2,4166 ± 198 2,428 ± 139a 
Potassium, mg 1,924 ± 218 2,185 ± 242 2,262 ± 190 
Vitamin A, IU 5,193 ± 798 5,886 ± 1058 6,911 ± 1455 
Vitamin C, mg 94.1 ± 17.3 79.4 ± 12. 5a 223.6 ±137.2 
Calcium, mg 750.4 ± 70.6 699.4 ± 68.7 818.4 ± 96.4 
Iron, mg 13.1 ± 1.6 14.0 ± 1.4 14.2 ±1.2 
Thiamin, mg 1.3 ± 0.2 1.2 ± 0.1 1.3 ± 0.2 
Riboflavin, mg 1.8 ± 0.3 2.1 ± 0.3 1.9 ± 0.3 
Niacin, mg 18.7 ± 3.8  23.1 ± 4.3 23.2 ± 3.9 
Folate, µg 386 ± 79 322 ± 43 324 ± 50 
1Data were derived from 4-d diet records, including one weekend day, collected during each test 
period. Data for the habitual diet were obtained at baseline before patty consumption began. 
aMeans without common superscripts differ (P ≤ 0.05). Data are means ± SE for 19 women. 
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Serum total cholesterol, LDL, HDL, and buoyant HDL2b cholesterol 
concentrations were significantly increased due to the consumption of the high-MUFA 
test patties (Figure 4 and 7; Table 10 and 13), whereas serum VLDL, RLP, and IDL 
particle concentrations were increased with the consumption of the low-MUFA test 
patties (Table 11 and Figure 5). 
 
 
 
TABLE 10 Major lipoprotein cholesterol concentrations (mmol/L) for women 
rotated through test ground beefs low in monounsaturated fatty acids 
(Low MUFA) or high in monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
Total 
cholesterol, 
mmol/L 
5.09 ± 
0.17 
5.21 ± 
0.17 
5.08 ± 
0.2 
5.34 ± 
0.19** 
LDL, mmol/L 3.23 ± 0.15 
3.24 ± 
0.14 
3.19 ± 
0.16 
3.35 ± 
0.15* 
HDL, mmol/L 1.56 ±  0.07 
1.61 ± 
0.06 
1.56 ± 
0.07 
1.63 ± 
0.07** 
1 Data are means ± SE for 19 women. 
* P ≤ 0.10; ** P ≤ 0.05 
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FIGURE 4 Changes from baseline in total cholesterol, LDL, and HDL 
cholesterol concentration (mmol/L) of women rotated through test ground beefs 
low in monounsaturated fatty acids (Low MUFA) or high in monounsaturated fatty 
acids (High MUFA). Values are expressed as mean ± SEM, n = 19.  * P ≤ 0.10; ** P 
≤ 0.05 
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FIGURE 5 Changes from baseline in triglycerides (TAG), intermediate density 
lipoprotein (IDL), very low density lipoprotein (VLDL) and remnant lipoprotein 
(RLP) cholesterol concentration (mmol/L) of women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA) or high in 
monounsaturated fatty acids (High MUFA). Values are expressed as mean ± SEM, 
n = 19.  * P ≤ 0.10; ** P ≤ 0.05 
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TABLE 11 TAG, VLDL, RLP, and IDL cholesterol concentrations for women 
rotated through test ground beefs low in monounsaturated fatty acids 
(Low MUFA) or high in monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
VLDL, mmol/L 0.30 ± 0.03 
0.35 ± 
0.03* 
0.34 ± 
0.03 
0.35 ± 
0.05 
RLP, mmol/L 0.75 ± 0.04 
0.85 ± 
0.05** 
0.80 ± 
0.05 
0.87 ± 
0.07 
IDL, mmol/L 0.67 0.03 
0.74 
0.04* 
0.71 
0.05 
0.77 
0.06 
TAG, mmol/L 1.12 ± 0.13 
1.12 ± 
0.1 
1.11 ± 
0.1 
1.09 ± 
0.10 
1 Data are means ± SE for 19 women; * P ≤ 0.10; ** P ≤ 0.05 
 
 
Though total LDL cholesterol was increased with high-MUFA patty 
consumption, no significant difference was seen within LDL III, LDL IV, or Lp(a) 
(Figure 6 and Table 12). 
 
 
 
TABLE 12 LDL III, LDL IV, and Lp(a) lipoprotein cholesterol concentrations 
for women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA) or high in 
monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
Dense LDL III, 
mmol/L 
0.5517 ± 
0.04 
0.5603 ± 
0.03 
0.5097 ± 
0.04 
0.525 ± 
0.04 
Dense LDL IV, 
mmol/L 
0.1741 ± 
0.01 
0.1782 ± 
0.01 
0.1705 ± 
0.09 
0.1877 ± 
0.01 
Lp(a), mmol/L 0.7778 ± 0.18 
0.7628 ± 
0.17 
0.771 ± 
0.17 
0.7423 ± 
0.18 
1 Data are means ± SE for 19 women. 
There were no significant differences among phases (P > 0.1) 
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FIGURE 6 Changes from baseline in LDL III, LDL IV, and Lp(a) cholesterol 
concentration (mmol/L) of women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA) or high in monounsaturated fatty acids 
(High MUFA). Values are expressed as mean ± SEM, n = 19. 
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FIGURE 7 Changes from baseline in HDL subfractions cholesterol 
concentrations (mmol/L) of women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA) or high in monounsaturated fatty acids 
(High MUFA). Values are expressed as mean ± SEM, n = 19. *** P ≤ 0.01 
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TABLE 13 HDL subfraction cholesterol concentrations for women rotated 
through test ground beefs low in monounsaturated fatty acids (Low 
MUFA) or high in monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
HDL2a, mmol/L 
0.233 ± 
0.02 
0.2285 ± 
0.02 
0.2368 ± 
0.02 
0.2409 ± 
0.02 
Bouyant HDL2b, 
mmol/L 
0.6484 ± 
0.05 
0.6732 ± 
0.04 
0.6369 ± 
0.05 
0.6909 ± 
0.05 
HDL3, mmol/L 
0.6743 ± 
0.02 
0.7031 ± 
0.02 
0.6892 ± 
0.02 
0.7004 ± 
0.02*** 
1 Data are means ± SE for 19 women. 
*** P ≤ 0.01 
 
VLDL and RLP particle concentration mirrored VLDL and RLP cholesterol 
increase with low-MUFA patty consumption. High-MUFA patty consumption did not 
have an effect on VLDL and RLP particle concentration (Figure 8 and Table 14). 
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FIGURE 8 Changes from baseline in VLDL and RLP particle concentration 
(nmol/L) of women rotated through test ground beefs low in monounsaturated fatty 
acids (Low MUFA) or high in monounsaturated fatty acids (High MUFA). Values 
are expressed as mean ± SEM, n = 19. **P ≤ 0.05  
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TABLE 14 VLDL and RLP particle concentrations  for women rotated through 
test ground beefs low in monounsaturated fatty acids (Low MUFA) 
or high in monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
VLDL, nmol/L 42.37 ± 4.59 53 ± 5.05
** 49.79 ± 4.34 51.26 ± 6.72 
RLP, nmol/L 120.68 ± 6.7 139.21 ± 8.81** 128.84 ± 9.26 137.47 ± 11.03 
1 Data are means ± SE for 19 women. 
** P ≤ 0.05 
 
Though LDL cholesterol was increased with the high-MUFA intervention, LDL, 
LDL III and LDL IV particle concentration, were not significantly increased (Figure 9 
and Table 15). The low-MUFA intervention did not have any effect on LDL or LDL 
subfraction particle concentrations. 
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FIGURE 9 Changes from baseline in LDL subfraction particle concentration 
(nmol/L) of women rotated through test ground beefs low in monounsaturated fatty 
acids (Low MUFA) or high in monounsaturated fatty acids (High MUFA). Values 
are expressed as mean ± SEM, n = 19. 
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TABLE 15 LDL and LDL subfraction particle concentrations for women rotated 
through test ground beefs low in monounsaturated fatty acids (Low 
MUFA) or high in monounsaturated fatty acids (High MUFA)1 
Lipoprotein  Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
LDL Total, 
nmol/L 835 ± 44 842 ± 36 824 ± 46 867 ± 41 
Dense LDL III, 
nmol/L 
201 ± 
15 196 ± 9.7 186 ± 16 192 ± 14 
Dense LDL IV, 
nmol/L 81.6 ± 5.5 84.2 ± 5.2 80.3 ± 4.5 89.5 ± 7.0 
1 Data are means ± SE for 19 women. 
There were no significant differences among phases (P > 0.1) 
 
Total HDL and buoyant HDL2b particle concentration increased with the 
consumption of the high-MUFA patties, while there were no significant change in HDL 
and HDL subfraction particle concentrations (Figure 10 and Table 16). 
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FIGURE 10 Changes from baseline in HDL particle concentration (nmol/L) of 
women rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA) or high in monounsaturated fatty acids (High MUFA). Values are 
expressed as mean ± SEM, n = 19. * P ≤ 0.10; *** P ≤ 0.01 
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TABLE 16 HDL particle concentrations for women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA) or high in 
monounsaturated fatty acids (High MUFA)1 
 Low MUFA 
Baseline  
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
HDL Total, 
nmol/L 10,648 ± 355 10,911 ± 370 10,723 ± 377* 11,129 ± 372 
HDL2a, nmol/L 
2,141 ± 
151 
2,085 ± 
167 
2,160 ± 
183 
2,212 ± 
179 
Bouyant 
HDL3b, nmol/L 
2,246 ± 172 2,327.05 ± 13 2,212 ± 181*** 2,397 ± 165 
HDL3, nmol/L 
6,262 ± 
206 
6,499 ± 
254 
6,351 ± 
228 
6,520 ± 
219 
1 Data are means ± SE for 19 women. 
* P ≤ 0.10; *** P ≤ 0.01 
 
 
 
No significant differences were seen for inflammatory markers, C-reactive 
protein (hs-CRP) or homocystine. Insulin also remained unchanged (Table 17). 
 
 
 
TABLE 17 C-reactive protein, homocysteine, and insulin levels pre- and post-test 
patty consumption1 
 Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
hs-CRP, mg/L 2.33 ± 0.51 
2.57 ± 
0.53 
3.59 ± 
0.74 
2.45 ± 
0.59 
Insulin, uIU/ml 7.25 ± 0.85 
7.31 ± 
0.79 
7.05 ± 
0.85 
7.49 ± 
0.83 
Homocysteine, 
µmol/L 
9.8 ± 
0.56 
9.73 ± 
0.57 
9.61 ± 
0.48 
10.13 ± 
0.63 
1 Data are means ± SE for 19 women. 
There were no significant differences among phases (P > 0.1) 
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Along with lipoprotein concentration, particle density and size was also measured, but 
no significant changes were seen (Table 18). 
 
 
 
TABLE 18 Particle density and size pre- and post-test patty consumption1 
 Low MUFA Baseline 
Low MUFA 
Final 
High MUFA 
Baseline 
High MUFA 
Final 
HDL mean 
density 
1.0922 ± 
0.0008 
1.0921 ± 
0.0008 
1.0928 ± 
0.0011 
1.0917 ± 
0.0009 
LDL mean 
density 
1.0294 ± 
0.0002 
1.0296 ± 
0.0002 
1.0292 ± 
0.0002 
1.0295 ± 
0.0002 
LDL mean size, 
nm 
20.18 ± 
0.02 
20.16 ± 
0.02 
20.22 ± 
0.03 
20.2 ± 
0.02 
1 Data are means ± SE for 19 women. 
There were no significant differences among phases (P > 0.1) 
 
 
 
Major plasma fatty acids were unchanged due to patty consumption (Figure 11 
and Table 19), while long chain fatty acids were consistently depressed by the low-
MUFA test patties (Figure 12 and Table 19). trans-Vaccenic acid (trans-aa) increased 
with the high-MUFA patties and trans-10, cis-12 conjugated linolenic acid (t10,c12 
CLA) increased with the low-MUFA test patties (Figure 13 and Table 19).  
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FIGURE 11 Changes from baseline in major plasma fatty acids of women rotated 
through test ground beefs low in monounsaturated fatty acids (Low MUFA) or high 
in monounsaturated fatty acids (High MUFA). Values are expressed as mean ± 
SEM, n = 19. 
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FIGURE 12 Changes from baseline in long chain plasma fatty acids of women 
rotated through test ground beefs low in monounsaturated fatty acids (Low MUFA) 
or high in monounsaturated fatty acids (High MUFA). Values are expressed as 
mean ± SEM, n = 19. ** P ≤ 0.05 
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FIGURE 13 Changes from baseline in trans plasma fatty acids of women rotated 
through test ground beefs low in monounsaturated fatty acids (Low MUFA) or high 
in monounsaturated fatty acids (High MUFA). Values are expressed as mean ± 
SEM, n = 19. * P ≤ 0.10; ** P ≤ 0.05 
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TABLE 19 Plasma fatty acid concentrations (g/100 g fatty acids) of women 
rotated through test ground beefs low in monounsaturated fatty acids 
(Low MUFA) or high in monounsaturated fatty acids (High MUFA)1 
Fatty Acid Pre Low MUFA 
Post Low 
MUFA 
Pre High 
MUFA 
Post High 
MUFA 
14:0 0.34± 0.05 
0.33 ± 
0.04 
0.39 ± 
0.05 
0.45 ± 
0.06 
14:1 0.06 ± 0.02 
0.08 ± 
0.03** 
0.05 ± 
0.02 
0.08 ± 
0.02 
16:0 18.15 ± 0.79 
18.27 ± 
0.47 
17.12 ± 
1.07 
18.61 ± 
0.59 
16:1 0.88 ± 0.19 
2.07 ± 
1.09 
1.25 ± 
0.23 
1.11± 
0.23 
18:0 8.63 ± 0.61 
8.19 ± 
0.27 
8.10 ± 
0.19 
8.39 ± 
0.31 
18:1t10 0.13 ± 0.05 
0.14 ± 
0.06 
0.08 ± 
0.03 
0.11± 
0.04 
18:1t11 0.18 ± 0.05 
0.21 ± 
0.06 
0.11 ± 
0.03 
0.24 ± 
0.06** 
18:1 17.82 ± 0.67 
18.59 ± 
0.59 
19.0 ± 
0.45 
19.25 ± 
0.62 
18:1c11 1.38 ± 0.08 
1.39 ± 
0.11 
1.44 ± 
0.07 
1.45 ± 
0.05 
18:2 31.20 ± 1.1 
32.27 ± 
1.02 
32.98 ± 
0.78 
32.17 ± 
1.11 
18:3 0.54 ± 0.06 
0.43 ± 
0.06 
0.48 ± 
0.06 
0.51 ± 
0.05 
18:2c9t11 0.06 ± 0.02 
0.06 ± 
0.02 
0.06 ± 
0.02 
0.07 ± 
0.02 
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TABLE 19     continued 
Fatty Acid Pre Low MUFA 
Post Low 
MUFA 
Pre High 
MUFA 
Post High 
MUFA 
18:2t10c12 0.06 ± 0.02 
0.14 ± 
0.04*  
0.06 ± 
0.02 
0.08 ± 
0.03 
20:2 0.35 ± 0.2 
0.80 ± 
0.35 
0.56± 
0.31 
0.68 ± 
0.29 
Unkn 1 2.03 ± 0.24 
1.88 ± 
0.11 
1.88 ± 
0.1 
1.84 ± 
0.11 
20:4 7.42 ± 0.46 
7.80 ± 
0.49 
7.50± 
0.38 
7.36 ± 
0.6541 
22:0 0.21 ± 0.12 
0.45 ± 
0.2 
0.65± 
0.3 
0.34 ± 
0.2* 
20:5 0.44 ± 0.08 
0.48 ± 
0.07 
0.49 ± 
0.07 
0.56 ± 
0.07 
24:0 0.31 ± 0.04 
0.21 ± 
0.04*** 
0.29 ± 
0.04 
0.26 ± 
0.04 
24:1 0.12 ± 0.03 
0.05 ± 
0.02** 
0.05 ± 
0.02 
0.08 ± 
0.02 
22:6 1.41 ± 0.16 
1.20 ± 
0.14 
1.23 ± 
0.14 
1.26 ± 
0.09 
Unkn 2 2.09 ± 0.57 
1.06 ± 
0.35** 
1.62 ± 
0.41 
1.26 ± 
0.35 
28:0 6.93 ± 1.47 
4.16 ± 
0.93** 
6.17 ± 
1.15 
4.85 ± 
1.04 
 1 Data are means ± SE for 19 women.  
* P ≤ 0.10; ** P ≤ 0.05; ***P ≤ 0.01 
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 Tables 20 and 21 present correlations between plasma fatty acids and lipoprotein 
cholesterol concentrations, LDL particle and size, HDL particle density, triglycerides, 
insulin, homocysteine and hs-CRP. Palmitoleic acid was significantly increased with 
low-MUFA patty consumption. and was positively correlated with homocysteine, 
VLDL, RLP and IDL, but negatively correlated with Lp(a). t10c12 CLA also was 
increased with the low-MUFA intervention and was correlated positively with 
triglycerides, hs-crp, insulin, VLDL, RLP, and LDL and negatively correlated with HDL 
cholesterol. Plasma trans-vaccenic acid was increased with high-MUFA patty 
consumption, and was correlated positively with total cholesterol, LDL, VLDL, RLP, 
IDL, LDL III and LDL IV. The low-MUFA intervention decreased 24:0, 24:1, Unknown 
2 and 28:0 plasma concentrations (Figure 12). Lignocenic acid (24:0) was negatively 
correlated with LDL IV and Lp(a), nervonic acid (24:1) was negatively correlated with 
triglycerides, LDL III, LDL IV, LDL mean density and Lp(a). Unknown 2 was 
negatively correlated with total cholesterol, LDL, LDL III, LDL IV, HDL 2b and Lp(a) 
and motanic acid (28:0) was negatively correlated with total cholesterol, LDL IV and 
HDL 2b and positively correlated with hs-CRP and insulin. 
 
 TABLE 20 Simple correlations between plasma fatty acids and cholesterol fractions, triglycerides, hs-CRP, insulin 
and homocysteine1 
 Total Cholesterol LDL       HDL TAG hs-CRP Insulin Homocysteine VLDL RLP IDL
16:0      0.28 0.29 NC NC NC NC NC NC NC NC 
16:1       
         
        
        
       
         
   
      
     
        
0.37 0.34 NC NC NC NC 0.39 0.23 0.23 NC 
18:1 NC 0.22 NC 0.44 NC NC NC 0.35 0.29 0.28 
18:1t11 NC NC NC NC NC NC NC 0.24 0.26 0.28 
18:1c11 0.33 0.33 NC 0.28 NC NC NC NC NC NC
18:2 NC NC 0.27 -0.23 -0.30 NC NC -0.29 NC NC
18:2 
c9t11 NC NC NC NC NC 0.23
 NC NC NC NC
18:2 
t10c12 NC NC -0.24
 0.42 0.27 0.29 NC 0.35 0.25 0.23 
20:4 NC NC 0.30 -0.47 -0.22 -0.27 NC -0.32 NC NC
22:6 NC NC NC -0.28 NC -0.26 -0.25 -0.35 -0.28 -0.27 
28:0 -0.26 NC NC NC 0.25 0.23 NC NC NC NC
1Correlations data pooled 76 measurements. 
All r values stated are significant, P ≤ 0.05; NC = no correlation 
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 TABLE 21 Simple correlations between plasma fatty acids and cholesterol subfractions, HDL mean density, LDL 
particle size and density1 
 LDL III LDL IV HDL 2b HDL 2a HDL 3 
HDL 
mean 
density 
LDL 
mean 
density 
LDL 
mean 
size 
Lp(a) 
16:0         0.27 NC NC NC NC NC NC NC NC
16:1        
        
         
        
        
         
         
        
0.30 NC NC NC 0.23 NC NC NC NC
18:0 NC NC NC NC NC NC -0.23 NC 0.34 
18:1t10 NC NC NC NC 0.24 NC NC NC NC
18:1t11 NC -0.31 NC 0.25 NC NC NC NC NC
18:1c11 0.45 0.38 NC NC NC NC NC NC NC
18:2 NC NC 0.30 NC NC NC NC NC NC
20:4 NC NC 0.32 NC NC NC NC NC NC
28:0 NC -0.25 -0.24 NC NC NC NC NC NC
1Correlations data pooled 76 measurements. 
All r values stated are significant, P ≤ 0.05; NC = no correlation 
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Discussion 
This study focused on the relationship between the ground beef MUFA:SFA ratio 
impact on total lipoproteins, lipoprotein subfractions and inflammatory markers 
associated with increased CVD risk. LDL and HDL particle diameter measurement were 
used to identify the presence of particularly atherogenic LDL or antiatherogenic HDL. 
Small, dense LDL are recognized as a risk factor for CVD, as this form of LDL is more 
susceptible to oxidative damage (6, 159) and promotes vascular inflammation (160, 
161). Measurement of HDL particle diameter is important, as it can be diagnostic of 
metabolic changes leading to small dense LDL and the antioxidative capacity of HDL 
(160). 
Because of recent advances in understanding of how inflammation instigates 
CVD (6), we also measured hs-CRP (162). Although a cross-sectional study showed a 
positive association between red meat and hs-CRP (163), the current intervention study 
showed no effect of ground beef consumption and hs-CRP levels.  
The high-MUFA ground beef contained nearly 4 g more MUFA per patty than 
did the low-MUFA ground beef, mainly in the form of oleic acid. Each participant on the 
high-MUFA diet consumed nearly 20 g more MUFA per week than those consuming the 
low-MUFA ground beef. This pattern of intake was documented in the dietary records. 
We chose not to strictly control dietary intake of nutrients by participants. We stipulated 
only that the ground beef patties replaced an equal portion of meat (beef or otherwise) 
that they normally would have consumed. This encouraged compliance and allowed us 
to evaluate the effects of the test ground beef patties in a more natural, free-living 
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setting. The data indicate that the increase in HDL-C without a significant increase in 
LDL cholesterol was due to the increased consumption of MUFA, probably oleic acid. 
Changes in plasma fatty acids supported the diet dependent changes in 
lipoprotein metabolism. Overall the low-MUFA intervention negatively impacted 
plasma triglycerides and increased 14:1 and t10c12 CLA, and decreased 24:0, 24:1, 
Unknown 2, and 28:0. For the most part these changes in plasma fatty acids correlated 
with undesirable effects such as increased VLDL, RLP, IDL, triglycerides, total 
cholesterol and decreased HDL-C although not all were observed after the low-MUFA 
intervention. It is possible that the increase in HDL-Cl, specifically HDL2b, seen with the 
high-MUFA intervention was due in part to the increase in plasma 18:1t11 and decrease 
in 22:0, as these fatty acids were positively correlated with HDL-C. Few studies have 
identified 28:0 in plasma, but the negative correlation seen between 28:0 (and Unknown 
2, a possible desaturation product of 28:0) and total cholesterol is consistent with the 
cholesterol lowering effects of D003. D003 is a mixture of very long chain fatty acids 
from sugar cane wax with octaconsanoic acid (28:0) as its main component. This 
mixture inhibits cholesterol metabolism in fibroblasts by modulating 3-hydroxy-3-
methyl coenzyme A (HMG-CoA) reductase activity and possibly HMG-CoA synthase 
activity (164). 
We recently reported the effects of two high-fat, hamburger preparations on 
cholesterol metabolism in a group of mildly hypercholesterolemic men (131). In that 
study, 10 men were first fed 35% fat hamburger high in SFA and trans-fat (MUFA:SFA 
= 0.95), and then were rotated to 35% hamburger high in MUFA (MUFA:SFA = 1.31). 
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As in the current study, neither of the test hamburger patties increased LDL-C. However, 
the high-SFA hamburger significantly reduced HDL-C and increased plasma TAG; these 
values returned to baseline values after consumption of the high-MUFA hamburger. The 
high-SFA ground beef also decreased LDL particle diameter, which was reversed by the 
high-MUFA ground beef. In this study, neither the low-MUFA ground beef nor the high-
MUFA ground beef affected LDL diameters (nm), density (g/gm3), or concentration 
(mmol/dL), which indicates that neither ground beef type affected LDL risk factors for 
CVD. However, the low-MUFA ground beef increased the concentrations of VLDL and 
RLP particles, effects that were not observed in women who consumed high-MUFA 
ground beef. RLP cholesterol is derived from VLDL remnants in fasting humans (165), 
and an increase in the concentration of RLP particles is considered a risk factor for CVD 
(166, 167). A unique and positive finding of this study is that the high-MUFA ground 
beef increased buoyant HDL2b cholesterol concentration and HDL2b particle 
concentration. There is convincing evidence that, of the subclasses of HDL particles, 
HDL2b cholesterol is cardioprotective because patients with premature CVD have 
reduced HDL2b (168), and families with low HDL2b have increased carotid intima-media 
thickness (associated with CVD) (27). Thus, high-MUFA ground beef not only increased 
HDL cholesterol, it increased the most cardioprotective subclass of HDL particles. 
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CHAPTER IV 
HIGH-OLEIC GROUND BEEF, EXERCISE, AND RISK FACTORS FOR 
CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMEN 
 
Introduction 
 Postmenopausal women are at high risk for cardiovascular disease (CVD) (169, 
170). Dietary interventions with low total fat consumption in postmenopausal women 
have not demonstrated significant reduction in CVD risk (171). While optimal dietary 
content continues to be debated and red meat consumption is discourage by the 
American Heart Association, the major monounsaturated fatty acids (MUFA) in ground 
beef, oleic acid, has been studied in more detail and found to lower LDL-cholesterol 
without affecting the beneficial HDL-cholesterol (HDL-C) (125, 126). In contrast to 
wavering dietary recommendations, existing literature broadly supports the beneficial 
effects of a single session of exercise on blood lipids in postmenopausal women (62, 
172). Exercise results in a decrease in LDL cholesterol (LDL-C) and an increase in 
HDL-C (118, 173, 174). Even a single session of endurance exercise can beneficially 
alter serum lipids (62, 175). Additionally, studies have found a reduction in hs-CRP and 
fasting glucose levels in response to exercise (162, 176, 177). Few studies to date have 
examined the metabolic and inflammatory response to exercise in combination with an 
increase in the monounsaturated:saturated fatty acid (MUFA:SFA) ratio of beef. 
Therefore, the objective of this study was to establish the relation between the 
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MUFA:SFA ratio of ground beef and the metabolic and inflammatory responses to a 
single session of aerobic exercise in postmenopausal women. 
 
Methods 
 Subjects. Twenty-nine postmenopausal women were recruited from the local 
Bryan/College Station, Texas community. Nineteen women completed the diet portion 
of the study, while seventeen completed both the exercise and diet portions. Detailed 
subject information can be found in Chapter III.  
Study design. Detailed study design can be found in Chapter III. Briefly, 17 
women were allotted to groups for a crossover design. The participants were asked to 
consume one low- or high-MUFA patty 5d/wk during the 6 wk test periods. Patty 
composition is listed in Table 2. 
Baseline testing. At study entrance, each subject underwent a complete history, a 
DEXA scan, height and body weight measurements, and peak oxygen consumption 
assessed with an automated metabolic gas-analysis system during a maximal effort 
graded exercise test according to the Bruce protocol (178). Heart rate and rhythm were 
monitored continuously throughout the graded exercise by a 12-lead electrocardiogram 
(EKG) and a rating of perceived exertion and manual blood pressures were obtained 
during the last 30 s of each stage and at maximal exercise. Review of graded exercise, 
EKG, and health history along with a physical exam were performed by a cardiologist. 
Exercise component. At the completion of each diet phase and once in the 
washout period, the participants underwent a bout of exercise. After abstaining from any 
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physical exercise for at least 3 d and fasting for 12 h, each subject reported to the J.L. 
Huffines Institute at Texas A&M University for a 24-h pre-exercise blood sampling. The 
following day subjects returned to the laboratory to complete the sub-maximal, 
experimental exercise session. Specifically, the subjects were asked to walk on a motor-
driven treadmill at 75% of their predetermined VO2peak for the duration required to 
expend 500 kcal of energy. Heart rate was monitored continuously and expired gases 
were measured every 10 min of exercise with a portable metabolic system (Medical 
Graphics VO2000) to ensure that the prescribed intensity and caloric expenditure were 
maintained. The speed and grade of the treadmill was adjusted as necessary to maintain 
the required intensity and caloric expenditure. Twenty-four hours after the acute exercise 
session, fasting blood samples were obtained for post-exercise analysis.  
Collection and handling of blood samples. Blood was collected from an arm 
vein prior to initiation of the dietary treatments, at the end of each diet phase 24 h before 
and after exercise. Plasma was harvested from the blood collected with 15% EDTA. 
Serum was harvested from the blood with clot separation. All serum and plasma samples 
were stored at -80°C. 
Fatty acid composition of plasma and test ground beef. Fatty acids were 
measured in the baseline plasma, plasma taken after 6 wk of each test beef treatment, 24 
h before and 24 h after exercise and expressed as a g/100 g total fatty acids analyzed (see 
Chapter III for procedure details). 
Blood chemistry and complete blood count. Serum samples were sent on the 
same day as the draw to St. Joseph Regional Health Center Bryan, TX for a complete 
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chemistry profile. Whole blood collected in a vaccutainer tube treated with 15% EDTA 
was sent on the same day as the draw to St. Joseph Regional Health Center for a 
complete blood count. The complete blood count was performed on the blood draws 
done 24 h before and after exercise to calculate the plasma volume shift caused by the 
acute exercise session.  
Lipoprotein analysis. Serum aliquots kept at -80°C were sent to SpectraCell 
Laboratories, Inc. (Houston, TX) for complete lipoprotein density and particle number 
analyses. A complete “Lipoprotein Particle Profile™” test was provided using the 
lipoprotein subgroup particle number analysis method (179). 
Diet records. Prior to each diet phase, and once during each phase, participants 
completed a 4-d record (to include one weekend day). The diet records were analyzed 
for nutrient composition to establish baseline observations, and encourage compliance 
with total patty consumption requirement. The records were analyzed using Nutritionist 
Pro (Axxya Systems, Stafford, TX). 
Statistical analysis. Data were analyzed as a paired t-test, comparing baseline 
(habitual) values to values after 6 wk on the test diet.  Thus, each participant served as 
her own control.  Because each participant randomly rotated through all three diets, 
reported values are means ± standard error of the mean (SE) for n = 17 observations. 
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Results 
Diet records indicated a change in monounsaturated fatty acids with no 
difference in energy percentage from protein or carbohydrate (Table 22). Detailed diet 
record analysis can be found in Chapter III. 
 
 
 
TABLE 22 Percent energy from fat, carbohydrate, and protein1 
 Baseline Low MUFA High MUFA 
Fat, % 34 ± 2.3 37 ± 1.6 37 ± 1.5 
Carbohydrate, % 48 ± 2.7 44 ± 2.1 45 ± 2.5 
Protein, % 17 ± 0.8 19 ± 0.9 18 ± 0.8 
1Data were derived from 4-d, including one weekend day, diet records collected during 
each test period. Data for habitual diet were obtained at baseline before patty 
consumption began. Means ± SE for 19 women. 
 
 
 
The average energy expenditure for the three acute exercise bouts were 502 ± 
0.58 kcal which lasted an average of 77 ± 1.35 min; there were no significant differences 
in energy expenditure among bouts (Table 23).  
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TABLE 23 Average energy expenditure and exercise duration with each bout of 
exercise1 
 Acute bout 1 Acute bout 2 Acute bout 3 
Energy expenditure, 
kcals 501 ± 0.73 502 ± 0.54 503 ± 1.5 
Duration, m 79 ± 2.7 77 ± 2.4 76 ± 2.1 
1Data are means ± SE for 17 women. 
There were no significant differences among phases (P > 0.1) 
 
 
 
Plasma volume increased significantly between pre-exercise and 24-h post-
exercise for acute bout during the high-MUFA intervention (Table 24). Therefore results 
are presented as raw data and those values based on plasma volume are also presented as 
shifted to account for plasma volume changes due to exercise.   
 
 
 
TABLE 24 Plasma volume shifts due to exercise1 
Exercise bout Mean plasma shift, % 
Exercise bout during Low-MUFA intervention 1.6 ± 0.92 
Exercise bout during washout 2.4 ± 1.15 
Exercise bout during high-MUFA intervention 3.6 ± 1** 
1Data are means ± SE for 17 women. 
**P ≤ 0.05 
 
 
 
Activity records reflected no significant change in activity throughout the three 
phases (Table 25). 
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TABLE 25 Average energy expenditure per day estimated from self reported 7-d 
activity records for each study phase1 
 Phase 1 Phase 2 Phase 3 
Energy expended, 
kcal/d 2,323 ± 85 2,399 ± 104 2,413 ± 110 
1Data are means ± SE for 14 women. 
There were no significant differences among phases (P > 0.1) 
 
 
 
TABLE 26 Cholesterol concentrations in response to a single exercise session as 
the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated 
fatty acids (High MUFA), or habitual diet (Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw total 
cholesterol, 
mmol/L 
5.30 ± 
0.17 
5.31 ± 
0.21 
5.26 ± 
0.22 
5.18 ± 
0.22 
5.02 ± 
0.15 
5.09 ± 
0.22 
Adjusted total 
cholesterol, 
mmol/L 
5.30 ± 
0.17 
5.39 ± 
0.22 
5.26 ± 
0.22 
5.36 ± 
0.22 
5.02 ± 
0.15 
5.21 ± 
0.22 
Raw LDL-C, 
mmol/L 
3.30 ± 
0.15 3.45 ± 0.19 
3.34 ± 
0.17 
3.36 ± 
0.16 
3.16 ± 
0.14 
3.26 ± 
0.18 
Adjusted LDL-
C, mmol/L 
3.30 ± 
0.15 
3.50 ± 
0.19* 
3.34 ± 
0.17 
3.48 ± 
0.18* 
3.16 ± 
0.14 
3.34 ± 
0.18* 
Raw HDL-C, 
mmol/L 
1.65 ± 
0.06 
1.58 ± 
0.07 
1.64 ± 
0.08 
1.62 ± 
0.05 
1.53 ± 
0.06 
1.51 ± 
0.06 
Adjusted HDL-
C, mmol/L 
1.65 ± 
0.06 
1.61 ± 
0.07 
1.64 ± 
0.08 
1.68 ± 
0.05 
1.53 ± 
0.06 
1.54 ± 
0.06 
1Data are means ± SE for 17 women. 
*P ≤ 0.1 
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FIGURE 14 Changes from baseline in cholesterol (mmol/L) in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty acids 
(High MUFA), or habitual diet (Washout). Values are expressed as mean ± SEM, n 
= 17. 
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FIGURE 15 Changes from baseline in cholesterol (mmol/L) when adjusted for 
plasma volume shifts of women in response to a single exercise session as the 
women rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA), high in monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout). Values are expressed as mean ± SEM, n = 17.  *P ≤ 0.01. 
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The exercise bouts had no significant effect on raw total cholesterol, LDL-C, or 
HDL-C, but when values are adjusted for plasma volume shifts, an increase in LDL-C 
24 h after the exercise bout was seen during the low-MUFA intervention and the 
washout period (Table 26; Figures 14 and 15). 
 Raw triglycerides were decreased after each exercise bout with the greatest 
response during the washout period. After adjustment for plasma volume shifts only the 
decrease in triglycerides seen after exercise during the washout period remained 
significant. Both raw and shifted VLDL cholesterol levels showed a significant ground 
beef effect as levels were decreased after exercise only during ground beef intervention. 
Raw RLP cholesterol was decreased after exercise during the high-MUFA intervention, 
but this effect was not seen when values were adjusted for plasma volume shifts. No 
changes in IDL cholesterol were observed after exercise (Table 27; Figures 16 and 17). 
Both raw and shifted LDL III and LDL IV cholesterol were left unchanged after 
the exercise bout in all phases. When adjusted for plasma volume shifts, Lp(a) was 
significantly increased after exercise during the washout phase and the high-MUFA 
intervention (Table 28; Figures 18 and 19). 
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FIGURE 16 Changes from baseline in triglycerides (TAG), intermediate density 
lipoprotein (IDL), very low density lipoprotein (VLDL), and remnant lipoprotein 
(RLP) cholesterol concentration (mmol/L) of women in response to a single exercise 
session as the women rotated through test ground beefs low in monounsaturated 
fatty acids (Low MUFA), high in monounsaturated fatty acids (High MUFA), or 
habitual diet (Washout). Values are expressed as mean ± SEM, n = 17. *P < 0.01; 
**P ≤ 0.05; ***P ≤ 0.001. 
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TABLE 27 TAG, VLDL, RLP, and IDL cholesterol concentrations of women in 
response to a single exercise session as the women rotated through 
test ground beefs low in monounsaturated fatty acids (Low MUFA), 
high in monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw 
TAG, 
mmol/L 
1.06 ± 
0.11 
0.94 ± 
0.1* 
1.11 ± 
0.11 
1.01 ± 
0.1* 
1.16 ± 
0.12 
0.94 ± 
0.07*** 
Adjusted 
TAG, 
mmol/L 
1.06 ± 
0.11 
0.96 ± 
0.1 
1.11 ± 
0.11 
1.05 ± 
0.11 
1.16 ± 
0.12 
0.96 ± 
0.07** 
Raw 
VLDL, 
mmol/L 
0.35 ± 
0.04 
0.27 ± 
0.03*** 
0.38 ± 
0.05 
0.31 ± 
0.05*** 
0.32 ± 
0.03 
0.32 ± 
0.04 
Adjusted 
VLDL, 
mmol/L 
0.35 ± 
0.04 
0.28 ± 
0.03*** 
0.36 ± 
0.05 
0.32 ± 
0.0487 
0.32 ± 
0.03 
0.33 ± 
0.04 
Raw RLP, 
mmol/L 
0.86 ± 
0.06 
0.80 ± 
0.06 
0.86 ± 
0.08 
0.79 ± 
0.08** 
0.72 ± 
0.05 
0.76 ± 
0.09 
Adjusted 
RLP, 
mmol/L 
0.86 ± 
0.06 
0.81 ± 
0.06 
0.86 ± 
0.08 
0.81 ± 
0.08 
0.72 ± 
0.05 
0.78 ± 
0.08 
Raw IDL, 
mmol/L 
0.75 ± 
0.05 
0.71 ± 
0.05 
0.75 ± 
0.06 
0.70 ± 
0.07 
0.66 ± 
0.04 
0.71 ± 
0.07 
Adjusted 
IDL, 
mmol/L 
0.75 ± 
0.05 
0.73 ± 
0.05 
0.75 ± 
0.06 
0.72 ± 
0.07 
0.66 ± 
0.04 
0.72 ± 
0.07 
1Data are means ± SE for 17 women. 
*P ≤ 0.01; **P ≤ 0.05; ***P ≤ 0.01 
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FIGURE 17 Changes from baseline in triglycerides (TAG), intermediate density 
lipoprotein (IDL), very low density lipoprotein (VLDL), and remnant lipoprotein 
(RLP) cholesterol concentration (mmol/L) when adjusted for plasma volume shift 
of women in response to a single exercise session as the women rotated through test 
ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet (Washout). Values are 
expressed as mean ± SEM, n = 17. **P ≤ 0.05; ***P ≤ 0.001. 
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TABLE 28 LDL subfraction cholesterol concentrations of women in response to 
a single exercise session as the women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw LDL III, 
mmol/L 
0.54 ± 
0.03 
0.51 ± 
0.03 
0.53 ± 
0.04 
0.53 ± 
0.03 
0.51 ± 
0.04 
0.52 ± 
0.03 
Adjusted 
LDL III, 
mmol/L 
0.54 ± 
0.03 
0.52 ± 
0.03 
0.53 ± 
0.04 
0.55± 
0.03 
0.51 ± 
0.04 
0.53 ± 
0.03 
Raw LDL 
IV, mmol/L 
0.18 ± 
0.01 
0.18 ± 
0.01 
0.19 ± 
0.02 
0.19 ± 
0.01 
0.18 ± 
0.01 
0.18 ± 
0.01 
Adjusted 
LDL IV, 
mmol/L 
0.18 ± 
0.01 
0.18 ± 
0.01 
0.19 ± 
0.02 
0.20 ± 
0.01 
0.18 ± 
0.01 
0.19 ± 
0.01 
Raw Lp(a), 
mmol/L 
0.71 ± 
0.19 
0.71± 
0.19 
0.67 ± 
0.19 
0.68 ± 
0.18 
0.69 ± 
0.19 
0.68 ± 
0.18 
Adjusted 
Lp(a), 
mmol/L 
0.71 ± 
0.19 
0.72 ± 
0.19 
0.67 ± 
0.19 
0.71 ± 
0.19** 
0.69 ± 
0.19 
0.71 ± 
0.19* 
1Data are means ± SE for 17 women. 
*P ≤ 0.1; **P ≤ 0.05 
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FIGURE 18 Changes from baseline in LDL subfraction cholesterol concentrations 
(mmol/L) of women in response to a single exercise session as the women rotated 
through test ground beefs low in monounsaturated fatty acids (Low MUFA), high 
in monounsaturated fatty acids (High MUFA), or habitual diet (Washout). Values 
are expressed as mean ± SEM, n = 17. 
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FIGURE 19 Changes from baseline in LDL subfraction cholesterol concentrations 
(mmol/L) when adjusted for plasma volume shift of women in response to a single 
exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty acids 
(High MUFA), or habitual diet (Washout). Values are expressed as mean ± SEM, n 
= 17. *P ≤ 0.01; **P ≤ 0.05.  
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 Raw buoyant HDL2b was decreased as a result of a high-MUFA exercise 
interaction, but when adjusted for plasma volume shifts no effect of exercise was 
observed (Table 29; Figures 20 and 21).  
 
 
 
TABLE 29 HDL subfraction cholesterol concentrations of women in response to 
a single exercise session as the women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw 
HDL2a, 
mmol/L 
0.24 ± 
0.02 
0.22 ± 
0.02 
0.26 ± 
0.02 
0.25 ± 
0.02 
0.21 ± 
0.02 
0.20 ± 
0.02 
Adjusted 
HDL2a, 
mmol/L 
0.24 ± 
0.02 
0.23 ± 
0.02 
0.26 ± 
0.02 
0.26 ± 
0.02 
0.21 ± 
0.02 
0.21 ± 
0.02 
Raw 
HDL2b, 
mmol/L 
0.70 ± 
0.03 
0.67 ± 
0.04 
0.72 ± 
0.05 
0.67 ± 
0.04* 
0.64 ± 
0.05 
0.63 ± 
0.04 
Adjusted 
HDL2b, 
mmol/L 
0.70 ± 
0.03 
0.68 ± 
0.04 
0.72 ± 
0.05 
0.70 ± 
0.04 
0.64 ± 
0.05 
0.64 ± 
0.04 
HDL3, 
mmol/L 
0.70 ± 
0.03 
0.69 ± 
0.02 
0.71 ± 
0.02 
0.70 ± 
0.02 
0.69 ± 
0.02 
0.67 ± 
0.02 
HDL3, 
mmol/L 
0.70± 
0.03 
0.70 ± 
0.02 
0.71 ± 
0.02 
0.72 ± 
0.02 
0.69± 
0.02 
0.69 ± 
0.02 
1Data are means ± SE for 17 women. 
*P ≤ 0.01 
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FIGURE 20 Changes from baseline in HDL subfraction cholesterol 
concentrations (mmol/L) of women in response to a single exercise session as the 
women rotated through test ground beefs low in monounsaturated fatty acids (Low 
MUFA), high in monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout). Values are expressed as mean ± SEM, n = 17. *P ≤ 0.01 
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FIGURE 21 Changes from baseline in HDL subfraction cholesterol 
concentrations (mmol/L) when adjusted for plasma volume shift of women in 
response to a single exercise session as the women rotated through test ground beefs 
low in monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty 
acids (High MUFA), or habitual diet (Washout). Values are expressed as mean ± 
SEM, n = 17. 
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 Raw VLDL particle concentrations mirrored concentrations of RLP cholesterol 
and were decreased after exercise during both low- and high-MUFA interventions, but 
not during the washout period. This effect remained when values were adjusted for 
plasma volume shifts. Raw RLP particle concentration is also decreased after exercise 
with both beef interventions, but not during the washout period. When adjusted for 
plasma volume shifts, no effect was observed for RLP particle concentrations (Table 30; 
Figures 22 and 23).    
 
 
 
TABLE 30 VLDL and RLP particle concentrations of women in response to a 
single exercise session as the women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw VLDL, 
nmol/L 
53.41 ± 
5.53 
39.12 ± 
4.6*** 
53.41 ± 
7.4 
46.29 ± 
7.18*** 
48.29 ± 
4.2 
48.35 ± 
6.35 
Adjusted 
VLDL, 
nmol/L 
53.41 ± 
5.53 
39.87 ± 
4.73*** 
53.41 ± 
7.4 
47.80 ± 
7.26** 
48.29 ± 
4.2 
49.13 ± 
6.17 
Raw RLP, 
nmol/L 
141.82 ± 
9.67 
127.41± 
10.14** 
139.47± 
12.59 
127.59 ± 
13.64** 
121.76 ± 
8.48 
127.76 ± 
14.24 
Adjusted 
RLP, nmol/L 
141.82 ± 
9.67 
129.85 ± 
10.63 
139.47± 
12.59 
131.88 ± 
13.76 
121.76 ± 
8.48 
130.01 ± 
14.08 
1Data are means ± SE for 17 women. 
**P ≤ 0.05; ***P ≤ 0.01 
 
 101
 
 
FIGURE 22 Changes from baseline in VLDL and RLP particle concentrations 
(nmol/L) in response to a single exercise session as the women rotated through test 
ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet (Washout). Values are 
expressed as mean ± SEM, n = 17. **P ≤ 0.05; ***P ≤ 0.001. 
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FIGURE 23 Changes from baseline in VLDL and RLP particle concentrations 
(nmol/L) changes from baseline when adjusted for plasma volume shifts in response 
to a single exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty acids 
(High MUFA), or habitual diet (Washout).  Values are expressed as mean ± SEM, n 
= 17. **P ≤ 0.05; ***P ≤ 0.001. 
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LDL particle concentration, when adjusted for plasma volume shifts, was 
increased after exercise during the high-MUFA intervention. No other effects were seen 
for LDL total, LDL III, and LDL particle concentrations (Table 31; Figures 24 and 25).   
 
TABLE 31 LDL particle concentrations in response to a single exercise session as 
the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated 
fatty acids (High MUFA), or habitual diet (Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw LDL, 
nmol/L 
869.4± 
37.3 
893.9 ± 
48.8 
880.9± 
43.8 
882.3± 
42.3 
824.5 ± 
41.8 
843.2± 
48.3 
Adjusted 
LDL, nmol/L 
869.4 ± 
37.3 
908.2 ± 
50.3 
880.9 ± 
43.8 
915.2 ± 
46.5* 
824.5 ± 
41.8 
862.3 ± 
49.6 
Raw LDL III, 
nmol/L 
199 ± 
10.4 
186.9± 
11.9 
194.8 ± 
15.4 
193.18± 
11.5 
185.3 ± 
13.4 
179.7 ± 
10.5 
Adjusted 
LDL III, 
nmol/L 
199.0 ± 
10.4 
189.9 ± 
12.3 
194.7 ± 
15.4 
200.6 ± 
12.7 
185.3 ± 
13.4 
183.8 ± 
10.8 
Raw LDL 
IV, nmol/L 
86 ± 
5.4 
86.3 ± 
4.9 
92.7 ± 
7.5 
89.18 ± 
6.4 
85.1 ± 
5.3 
88.2 ± 
4.5 
LDL IV, 
nmol/L 
86 ± 
5.4 
87.7 ± 
5.0 
92.7 ± 
7.5 
92.6 ± 
6.9 
85.1 ± 
5.3 
90.4 ± 
4.8 
1Data are means ± SE for 17 women. 
P ≤ 0.1 
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FIGURE 24 Changes from baseline in LDL subfraction particle concentrations 
(nmol/L) in response to a single exercise session as the women rotated through test 
ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet (Washout). Values are 
expressed as mean ± SEM, n = 17. 
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FIGURE 25 Changes from baseline in LDL subfraction particle concentration 
(nmol/L) when adjusted for plasma volume shifts in response to a single exercise 
session as the women rotated through test ground beefs low in monounsaturated 
fatty acids (Low MUFA), high in monounsaturated fatty acids (High MUFA), or 
habitual diet (Washout). Values are expressed as mean ± SEM, n = 17. *P ≤ 0.10. 
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Exercise and exercise diet interactions had no significant effect on HDL total and 
subclasses particle concentrations (Table 32; Figures 26 and 27). 
 
 
 
TABLE 32 HDL particle concentrations in response to a single exercise session 
as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated 
fatty acids (High MUFA), or habitual diet (Washout)1 
 
Low 
MUFA 
pre- 
exercise 
Low 
MUFA  
post- 
exercise 
High 
MUFA 
pre- 
exercise 
High 
MUFA 
post- 
exercise 
Washout 
pre- 
exercise 
Washout  
post- 
exercise 
Raw HDL, 
nmol/L 
11,285± 
348 
10,879 ± 
358 
11,370 ± 
390 
11,107 ± 
265 
10,612 ± 
318 
10,434± 
346 
Adjusted HDL, 
nmol/L 
11,285 ± 
348 
11,050 ± 
383 
11,370 ± 
390 
11,486 ± 
256 
10,612 ± 
318 
10,661 ± 
344 
Raw HDL2a, 
nmol/L 
2,268 ± 
173 
2,083 ± 
182 
2,399 ± 
177 
2,294 ± 
150 
1,937 ± 
147 
1,921 ± 
142 
Adjusted HDL2a, 
nmol/L 
2,268 ± 
173 
2,115 ± 
187 
2,399 ± 
177 
2,365 ± 
147 
1,937 ± 
147 
1,961 ± 
143 
Raw HDL2b, 
nmol/L 
2,424 ± 
131 
2,320 ± 
146 
2,475 ± 
173 
2,361 ± 
136 
2,206 ± 
166 
2,202 ± 
141 
Adjusted HDL2b, 
nmol/L 
2,423 ± 
131 
2,356 ± 
150 
2,474 ± 
173 
2,444 ± 
142 
2,206 ± 
166 
2,248 ± 
142 
Raw HDL3, 
nmol/L 
6,593 ± 
246 
6,476 ± 
213 
6,496 ± 
235 
6,452 ± 
181 
6,470 ± 
209 
6,311 ± 
245 
Adjusted HDL3, 
nmol/L 
6,593 ± 
246 
6,579 ± 
231 
6,496 ± 
235 
6,678 ± 
189 
6,470 ± 
209 
6,452 ± 
248 
1Data are means ± SE for 17 women. 
There were no significant differences among phases (P > 0.1) 
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FIGURE 26 Changes from baseline in HDL lipoprotein particle concentration 
(nmol/L) in response to a single exercise session as the women rotated through test 
ground beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet (Washout). Values are 
expressed as mean ± SEM, n = 17. 
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FIGURE 27 Changes from baseline in HDL lipoprotein particle concentration 
(nmol/L) when adjusted for plasma volume in response to a single exercise session 
as the women rotated through test ground beefs low in monounsaturated fatty acids 
(Low MUFA), high in monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout). Values are expressed as mean ± SEM, n = 17. 
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hs-CRP was significantly increased after the exercise bout in all three phases. 
This effect remained after adjustments for plasma volume shift were made. 
Homocysteine was significantly increased after exercise during the washout phase. After 
adjustment for plasma volume shifts, this effect became more significant. Insulin was 
unchanged after exercise (Table 33). 
 
 
 
TABLE 33 C-reactive protein, homocysteine and insulin levels in response to a 
single exercise session as the women rotated through test ground 
beefs low in monounsaturated fatty acids (Low MUFA), high in 
monounsaturated fatty acids (High MUFA), or habitual diet 
(Washout)1 
 
 
Low 
MUFA 
Pre 
Exercise 
Low 
MUFA 
Post 
Exercise 
High 
MUFA 
Pre 
Exercise 
High 
MUFA 
Post 
Exercise 
Washout 
Pre 
Exercise 
Washout 
Post 
Exercise 
Raw hs-CRP, 
mg/L 
2.32 ± 
0.45 
2.98 ± 
0.72* 
2.261 ± 
0.58 
3.39 ± 
0.73** 
1.98 ± 
0.42 
2.91 ± 
0.69** 
Adjusted hs-
CRP, mg/L 
2.32 ± 
0.45 
3.26 ± 
0.74* 
2.26 ± 
0.58 
3.78 ± 
0.73** 
1.98 ± 
0.42 
2.97 ± 
0.71** 
Raw insulin, 
µIU/ml 
6.88 ± 
0.79 
6.18 ± 
0.73 
7.28 ± 
0.9 
6.36 ± 
0.51 
6.51 ± 
0.57 
6.78 ± 
0.63 
Adjusted 
insulin, µIU/ml 
6.88 ± 
0.79 
6.30 ± 
0.77 
7.28 ± 
0.9 
6.57 ± 
0.52 
6.51 ± 
0.57 
6.92 ± 
0.63 
Raw 
homocysteine, 
µmol/L 
9.71 ± 
0.62 
9.49 ± 
0.44 
9.85 ± 
0.72 
9.78 ± 
0.78 
9.28 ± 
0.48 
9.94 ± 
0.64* 
Adjusted 
homocysteine, 
µmol/L 
9.71 ± 
0.62 
9.64 ± 
0.47 
9.85 ± 
0.72 
10.11 ± 
0.78 
9.28 ± 
0.48 
10.16 ± 
0.65** 
1Data are means ± SE for 17 women. 
*P ≤ 0.1; **P ≤ 0.05; 
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HDL mean density and LDL size increased while LDL mean density decreased 
after exercise during the low-MUFA intervention. HDL density was increased after 
exercise during the high-MUFA intervention. There were no changes in HDL or LDL 
mean density or LDL size after exercise during the washout period (Table 34). 
 
 
 
TABLE 34 Particle density and size in response to a single exercise session as the 
women rotated through test ground beefs low in monounsaturated 
fatty acids (Low MUFA), high in monounsaturated fatty acids (High 
MUFA), or habitual diet (Washout)1 
 
Low 
MUFA 
Pre 
Exercise 
Low 
MUFA 
Post 
Exercise 
High 
MUFA 
Pre 
Exercise 
High 
MUFA 
Post 
Exercise 
Washout 
Pre 
Exercise 
Washout 
Post 
Exercise 
HDL mean 
density 
1.0918 ± 
0.0008 
1.0938 ± 
0.0011*** 
1.0912 ± 
0.0009 
1.0931 ± 
0.001** 
1.0877 ± 
0.005 
1.0916 ± 
0.0009 
LDL mean 
density 
1.0295 ± 
0.0002 
1.0287 ± 
0.0002** 
1.0296 ± 
0.0002 
1.0293 ± 
0.0002 
1.0292 ± 
0.0003 
1.0295 ± 
0.0003 
LDL mean 
size, nm 
20.17 ± 
0.02 
20.27 ± 
0.03*** 
20.19 ± 
0.02 
20.22 ± 
0.02 
20.22 ± 
0.03 
20.20 ± 
0.03 
1Data are means ± SE for 17 women. 
 **P ≤ 0.05; ***P ≤ 0.01 
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 Plasma fatty acids are expressed as g/100 g fatty acids (Table 35). Because the 
values have no dependence on plasma volume, no adjustment for plasma volume shifts 
was needed. Palmitoleic acid, cis-vaccenic, and α-linolenic were decreased after exercise 
only during the high-MUFA intervention. Oleic acid was decreased after exercise during 
the washout period and high-MUFA intervention. Plasma 20:2 was increased with 
exercise during the washout period. c9t11 CLA, unknown 1 and 20:5 were decreased 
during the low-MUFA intervention after the exercise bout (Figures 28 and 29; Table 35). 
 
 
 
TABLE 35 Plasma fatty acid levels in response to a single exercise session as the 
women rotated through test ground beefs low in monounsaturated 
fatty acids (Low MUFA), high in monounsaturated fatty acids (High 
MUFA), or habitual diet (Washout)1 
Fatty 
Acid 
Pre Low 
MUFA 
Post Low 
MUFA 
Pre 
Washout 
Post 
Washout 
Pre High 
MUFA 
Post High 
MUFA 
14:0 0.32 ± 0.05 
0.31 ± 
0.05 
0.42 ± 
0.05 
0.36 ± 
0.06 
0.43 ± 
0.02 
0.38 ± 
0.03 
14:1 0.07 ± 0.02 
0.08 ± 
0.03  
0.05 ± 
0.02 
1.28 ± 
1.21 
0.09 ± 
0.01 
0.08 ± 
0.01 
16:0 18.35 ± 0.52 
18.32 ± 
0.78 
17.71 ± 
1.27 
16.14 ± 
1.33 
18.56 ± 
0.24 
17.66 ± 
0.25  
16:1 2.15 ± 1.22 
0.99 ± 
0.22 
1.09 ± 
0.21 
0.95 ± 
0.19 
1.12 ± 
0.09 
1.0 ± 
0.08* 
18:0 8.20 ± 0.30 
8.20 ± 
0.30 
8.62 ± 
0.71 
8.19 ± 
0.32 
8.37 ± 
0.12 
8.0 ± 
0.09 
18:1t10 0.13 ± 0.06 
0.09 ± 
0.05 
0.10 ± 
0.04 
0.10 ± 
0.04 
0.12 ± 
0.02 
0.09 ± 
0.01 
18:1t11 0.22 ± 0.06 
0.11 ± 
0.03 
0.15 ± 
0.05 
0.21 ± 
0.07 
0.26 ± 
0.03 
0.24 ± 
0.02 
18:1 18.57 ± 0.66 
18.13 ± 
0.75 
19.0 ± 
0.38 
17.44 ± 
0.58** 
19.28 ± 
0.25 
17.35 ± 
0.18*** 
18:1c11 1.37 ± 0.12 
1.42 ± 
0.09 
1.45 ± 
0.08 
1.42 ± 
0.09 
1.45 ± 
0.02 
1.35 ± 
0.03 
18:2 32.14 ± 1.13 
31.57 ± 
1.17  
31.71 ± 
1.23 
30.75 ± 
1.06 
31.94 ± 
0.44 
31.55 ± 
0.44 
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TABLE 35 Continued 
Fatty Acid Pre Low MUFA 
Post Low 
MUFA 
Pre 
Washout 
Post 
Washout 
Pre High 
MUFA 
Post 
High 
MUFA 
18:3 0.42 ± 0.07 
0.37 ± 
0.05 
0.54 ± 
0.07 
0.45 ± 
0.03 
0.52 ± 
0.02 
0.45 ± 
0.03* 
18:2c9t11 0.07 ± 0.02  
0.04 ± 
0.02* 
0.06 ± 
0.02 
0.05 ± 
0.03 
0.07 ± 
0.01 
0.04 ± 
0.01 
18:2t10c12 0.11 ± 0.04 
0.05 ± 
0.02 
0.04 ± 
0.02 
0.05 ± 
0.02 
0.08 ± 
0.01 
0.10 ± 
0.01  
20:2 0.67 ± 0.37 
0.28 ± 
0.13 
0.32 ± 
0.20 
0.91 ± 
0.37* 
0.72 ± 
0.12 
0.47 ± 
0.11 
Unkn 1 1.88 ± 0.12 
1.69 ± 
0.11*** 
2.13 ± 
0.27 
1.86 ± 
0.14 
1.86 ± 
0.04 
1.79 ± 
0.04 
20:4 8.05 ± 0.51 
10.53 ± 
2.38 
7.17 ± 
0.28 
7.83 ± 
0.79 
7.36 ± 
0.26 
7.78 ± 
0.19 
22:0 0.19 ± 0.12 
0.07 ± 
0.03 
0.53 ± 
0.31 
0.42 ± 
0.25  
0.36 ± 
0.08 
0.43 ± 
0.09 
20:5 0.50 ± 0.08 
0.41 ± 
0.08** 
0.54 ± 
0.11 
0.45 ± 
0.08 
0.57 ± 
0.03 
0.51 ± 
0.03 
24:0 0.22 ± 0.04 
0.25 ± 
0.04 
0.27 ± 
0.05 
0.38 ± 
0.09 
0.26 ± 
0.02 
0.25 ± 
0.02 
24:1 0.06 ± 0.02 
0.07 ± 
0.02 
0.08 ± 
0.02 
0.11 ± 
0.04 
0.09 ± 
0.01 
0.07 ± 
0.01 
22:6 1.29 ± 0.15 
1.28 ± 
0.13 
1.34 ± 
0.14 
1.25 ± 
0.19 
1.25 ± 
0.04 
1.16 ± 
0.06 
Unkn 2 1.11 ± 0.39 
1.15 ± 
0.23 
1.67 ± 
0.46 
2.18 ± 
0.53 
1.31 ± 
0.14 
2.13 ± 
0.19 
28:0 4.19 ± 1.04 
4.58 ± 
0.70 
6.21 ± 
1.26 
7.21 ± 
1.49 
5.0 ± 
0.42 
7.14 ± 
0.55 
1Data are means ± SE for 17 women. 
*P ≤ 0.01; **P ≤ 0.05; ***P ≤ 0.01 
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FIGURE 28 Changes from baseline in major plasma fatty acids in response to a 
single exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty acids 
(High MUFA), or habitual diet (Washout). Values are expressed as mean ± SEM, n 
= 17. **P ≤ 0.05; P ≤ 0.01  
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FIGURE 29 Change from baseline in trans plasma fatty acids in response to a 
single exercise session as the women rotated through test ground beefs low in 
monounsaturated fatty acids (Low MUFA), high in monounsaturated fatty acids 
(High MUFA), or habitual diet (Washout). Values are expressed as mean ± SEM, n 
= 17. P ≤ 0.10 
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Discussion 
 Adjusting values due to plasma volume shifts is controversial. Some consider the 
adjustment for plasma volume changes essential when comparing pre- and post-exercise 
markers so as to not confuse exercise effects with simple changes in plasma volume. 
Others confirm that plasma volume shifts as a result of exercise, but argue that it is the 
concentration of the parameter that is of most biological significance, irrespective of 
plasma volume shifts. To address both exercise effects independent of volume shifts and 
potential biological effects, both raw and adjusted data were presented. Whereas most 
exercise reduces plasma volume, many other factors like hydration, heat stress, physical 
training, exercise duration and exercise intensity can influence plasma volume. 
Frequently, variation in findings can be attributed to plasma volume shifts and whether 
or notadjustments were made (180). In this study, an average increase in plasma volume 
was observed in each phase, but was statistically significant only after exercise during 
the high-MUFA intervention. This increase in plasma volume most likely was due to 
access to water during exercise and encouraged fluid consumption post-exercise. 
 Activity records reported desired consistent activity throughout the three study 
phases. When estimated calories burned from the activity records are compared to 
caloric intake, a negative energy balance was suggested. In light of the suggested 
negative energy balance, stable weight was maintained throughout the study. The 
discrepancy may be due to under-reporting or estimating dietary intake and over-
reporting or estimating activity.   
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 Although exercise is a common recommendation for increasing HDL-C, no 
change in HDL-C or HDL particle number with exercise was seen in this study. Also, no 
changes in the HDL subfractions were observed except a decrease in buoyant HDL2b 
after exercise during the high-MUFA intervention. Measurements were taken only at 24-
h post-exercise and many of studies reported an increase in HDL-C either immediately 
after exercise (62, 122) or at 48-h post-exercise (122). Gordon et al. (122) attributes the 
delayed response in adjusted HDL-C to an exercise session lasting less than 2 h which 
was the case for the current study. The women in this study, though postmenopausal, had 
higher than average baseline HDL-C. It is possible a larger volume of work is required 
to elicit a post-exercise increase in HDL-C when baseline levels are high (181). During a 
diet intervention x exercise interaction study in which sedentary men were supplemented 
omega-3 fatty acids, no change in total HDL-C or HDL-C subfractions was observed 
after the 3 d of exercise. The current study only utilized one isolated bout of exercise, 
and no change in HDL particle distribution was observed. 
 Raw and adjusted triglycerides were decreased after exercise along with a 
reduction in raw VLDL after exercise during both ground beef interventions. An 
increase in lipoprotein lipase after exercise may be responsible for the reduction in 
VLDL, other triglyceride rich lipoproteins, and triglycerides (182). A beneficial increase 
in LDL diameter was observed after exercise during the low-MUFA intervention, which 
was consistent to the exercise effects seen after three consecutive days of exercise (181). 
 An increase in inflammatory markers is viewed as a negative (8). Raw hs-CRP 
was increased after every bout of exercise, but was elevated acutely as a response to the 
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stress of exercise. When individuals train over time, the inflammatory response to 
exercise is reduced (183). Treadmill walking induces microtrauma to the muscle fibers 
resulting in an acute inflammatory state and leads to muscle repair and hypertrophy 
(184). Cholesterol and fatty acids are an important component of cellular membranes. As 
muscles repair and grow, the demand for cholesterol increases. The increased cellular 
need for cholesterol and fatty acids after exercise for muscle repair and growth (185), 
may explain the shift in lipoprotein metabolism seen in this study. LDL cholesterol and 
LDL particle size increased and triglycerides and VLDL decreased. That mirrors the 
increased extrahepatic tissue demand for cholesterol and fatty acids necessary for muscle 
repair and growth. The reduction in HDL2b supports this notion as reverse cholesterol 
transport is likely reduced during this time of skeletal muscle repair and growth.  
 In summary, an acute bout of exercise independent and in conjunction with 
dietary interventions can elicit beneficial effects such as a reduction in plasma 
triglycerides, VLDL, and RLP along with an increase in LDL diameter. 
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CHAPTER V  
CONCLUSIONS  
 
 As time progresses more diseases stemming from poor lifestyle choices, like 
CVD, are plaguing industrialized nations. The evaluation of diet and exercise regimens 
to prevent such diseases would therefore seem important.  Epidemiological studies have 
shown that red meat consumption is associated with an increased risk of CVD (186, 
187), but the epidemiological data remain unclear (188) Red meat contributes important 
nutrients to the diet, including iron, vitamin B12, and high-quality protein (189), but 
recommendations for a “heart healthy” diet do not encourage red meat consumption 
likely due to its saturated fat content (190). The fatty acid profiles in beef can be altered 
through production methods including feed type, length of feeding, age at time of 
slaughter and genetics of the cattle (131, 132, 139). The present studies aimed to 
evaluate the effect of different fatty acids in beef on CVD risk factors. An earlier, 
recently published study was designed similarly to the present studies, and evaluated the 
effects of the MUFA:SFA ratio of hamburger on lipoprotein and lipid profiles in mildly 
hypercholesterolemic men. When looking at the overall effects of the MUFA:SFA ratio 
of ground beef on major cholesterol fractions and triglycerides, one effect remains 
consistent through three independent studies: the high-MUFA ground beef (MUFA:SFA 
≥ 1.10) significantly increased HDL cholesterol (Table 36). While many other risk factor 
are associated with CVD and are evaluated in the present studies total HDL cholesterol 
is most consistently negatively associated with CVD risk (191). 
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TABLE 36 Overall effects of MUFA:SFA ratio of ground beef on major 
cholesterol fractions and triglycerides1 
 MUFA:SFA effect on cholesterol fractions and triglycerides 
Study 1 0.71 0.83 1.10 
 Total ±2 Total ± Total ± 
 LDL  ± LDL  ± LDL  ± 
 HDL ± HDL ± HDL ↑ 
 TAG ± TAG ± TAG ± 
    
Study 2  0.90 1.3 
  Total ± Total ↑ 
  LDL  ± LDL  ↑ 
  HDL ± HDL ↑ 
  TAG ± TAG ± 
    
Study 3  0.95 1.31 
  Total --- Total --- 
  LDL  ± LDL  ± 
  HDL ↓ HDL ↑ 
  TAG ↑ TAG ↓ 
1Study 1 = Study from Chapter II, Study 2 = Study from Chapter III, Study 3 = Adams et 
al. (131). 
2± = no change, --- = not reported, ↑ = increased, ↓ = decreased 
 
 
 
 It is not the intention of the study to recommend daily consumption of one high-
MUFA ground beef serving, but these studies failed to show consistent negative effects 
of ground beef intake. These studies argue that ground beef, especially high-MUFA 
ground beef, can be incorporated into a healthy diet to provide beneficial health effects 
with exercise or diet alone. To further evaluate the inconsistent negative effects of 
ground beef seen in these studies such as, increased HDL density, LDL, VLDL, RLP 
and IDL cholesterol additional studies which measure theses biomarkers are needed. 
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When diet influenced lipid metabolism, exercise attenuated the diet effects returning the 
cholesterol concentrations to baseline. 
 The area of lipoprotein metabolism, especially that of HDL subfractions and 
functionality, has many unanswered questions (12). It is known total HDL cholesterol is 
a strong negative predictor of CVD events. Desired characteristics of HDL and HDL 
subfractions are equivocal. Even less is known about the effects of dietary interventions 
on HDL functionality. As more is learned about lipoprotein metabolism and 
functionality, how it relates to the CVD process and the impacts of diet and exercise, 
reliable recommendations to improve or preserve health can be given.   
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